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Abstract
Type 2 diabetes affects 90% of people who live with this chronic disease. A primary goal of
healthcare professionals is to assist patients with Type 2 diabetes to achieve optimal glycemic
control to prevent the devastating complications of this disease. Research has demonstrated that
optimal glycemic control can minimize or prevent macrovascular complications such as heart
attack or stroke and the microvascular complications of retinopathy, nephropathy, and
neuropathy. Historically insulin has been one of the last agents to be added in type 2 diabetes
despite its efficacy and long term treatment data. Reluctance by both patients and clinicians to
add insulin to treatment regimens, a phenomenon known as psychological insulin resistance,
remains an issue. The perception of stress and ways of coping in participants who were initiating
insulin therapy were examined in this research. The relationship between participants’ stress and
the education they received was also examined. The education provided was based upon a
Registered Nurses Association of Ontario (RNAO) Best Practice Guideline (BPG).
In a pretest / posttest design, participants (N = 105) who were seen at a Diabetes Education
Centre for initiation of insulin therapy were surveyed prior to receiving insulin initiation
education and six weeks following the initiation of their insulin therapy. Three surveys were
completed, the Perceived Stress Scale, Ways of Coping Questionnaire, and The Confidence in
Administering Insulin and Managing Diet Scale at the pre/post timepoints. A BPG evaluation
tool was also completed during the posttest appointment. A mediated regression analysis
demonstrated coping to be a mediator of the relationship between stress and insulin self-efficacy.
There was a statistically significant decrease in participants’ stress and a statistically significant
increase in insulin self-efficacy. Analysis of the BPG evaluation tool demonstrated that 80% of
the BPG content was recalled by participants. This study provided evidence that the needs of
these patients can be met with structured education through the use of a Best Practice Guideline
and the assessment of patient stress and coping can improve patient self-efficacy with insulin
therapy and decrease their stress burden.

Keywords
Type 2 diabetes, insulin initiation, stress, coping, best practice guidelines, Registered Nurses
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Chapter 1
1.

Introduction

This chapter provides the foundation for the development of the research presented in this
dissertation. It begins with the research questions that were examined, articulates the elements of
this integrated thesis, and concludes with an executive summary of the dissertation.

1.1 Background
Evidence regarding the earliest awareness of diabetes dates back to 1552 BC with the description
by an Egyptian physician of the “passing of too much urine” (Canadian Diabetes Association,
2013c). Today as diabetes continues to increase throughout the world, particularly Type 2
diabetes, a person dies every 6 seconds from this chronic disease (International Diabetes
Federation, 2013). In Canada, approximately 2.6 million Canadians are living with diabetes
(Public Health Agency of Canada, 2011). Although diabetes care continues to evolve and the
number of pharmacologic agents used to treat diabetes has expanded greatly, the reality is that
approximately half of Canadians living with type 2 diabetes do not achieve the recommended
clinical practice guideline targets for glycemic control (Harris, Kapor, Lank, Willan, & Houston,
2010a; Leiter et al., 2013a).
Achieving optimal blood glucose control is critical in diabetes to minimize the devastating
complications of this disease. Persons living with diabetes have mortality rates at least two times
higher than those without diabetes (Public Health Agency of Canada, 2011a). The risk of
macrovascular complications such as heart attack, stroke or microvascular complications such as
renal failure, retinopathy, and neuropathy are all increased in the presence of diabetes. The
importance of glycemic control was demonstrated in the landmark research of the United
Kingdom Prospective Diabetes Study (UKPDS) which examined and established the standards
for blood glucose control in Type 2 diabetes (1998). Study findings revealed a 12% lower risk of
developing any diabetes-related endpoints with substantial risk-reduction in microvascular
complications for patients in the intensive glucose group compared to patients in the control
group. The findings became the foundation for developing the standard of care for diabetes
clinical management.
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The reasons for not achieving target blood glucose control are complex, multifactorial, and must
take into consideration both the pathophysiologic and psychological elements of living with
diabetes. As a nurse practitioner, my clinical practice has included many patients who have
struggled with their diabetes self-management. The need to add insulin to a therapeutic regimen
has often resulted in anxiety for patients and has frequently been met with resistance or refusal.
This study was an important way for me to fulfill my professional commitment as a researcher
and educator to add to the diabetes research findings. The results provide new knowledge
regarding the education and initiation of insulin therapy in adult patients with Type 2 diabetes.

1.2 Significance
As members of the interprofessional diabetes team, nurses play a key role in the education of
people living with diabetes. The majority of diabetes care originates in the primary care setting
with the focus on enhancing diabetes self-management skills (Clement, Harvey, Rabi, Roscoe, &
Sherifali, 2013). The role of the nurse in out-patient diabetes care has a strong focus on
education and assisting patients to develop effective self- management behaviours. In a metaanalysis of the effectiveness of structured care to improve the management of patients with
diabetes, Renders (2001) found that enhancing the role of the nurse led to improvements in
patient outcomes and process of care. Nurses are frequently involved with medication
management and have been shown to assist with improving glycemic control (Barr-Taylor et al.,
2003; Hearnshaw et al., 2006; The California Medi-Cal Type 2 Diabetes Study., 2004; Wens et
al., 2008). With the recognition that nursing care must be evidenced-based, the use of best
practice guidelines (BPG) provides the synthesis of research and clinical expertise required to
support the highest caliber of nursing care. Utilizing and evaluating BPGs are integral to
effective and efficient nursing care.

1.3 Research Purpose and Questions
The purpose of this research was to examine the relationships between perceived stress and ways
of coping of patients with Type 2 diabetes who began insulin therapy and received diabetes
education guided by the Registered Nurses Association of Ontario (RNAO) Best Practice
Guideline (BPG) for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes
(2009). The research questions were:
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1. What is the relationship between perceived stress and diabetes education guided by the
RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes
who initiate insulin therapy?
2. What is the relationship between perceived stress, ways of coping in adult patients and the
initiation of insulin therapy in adults with Type 2 diabetes?
3. What is the level of participant recall of diabetes education using the RNAO BPG for the
Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes as evaluated by a
novel BPG evaluation tool?
4. What is the patient experience of initiating insulin therapy when receiving structured Best
Practice Guideline diabetes education?”
The research findings for question #1 and question #2 are discussed in chapter 3, “Coping as a
Mediator of Stress with the Initiation of Insulin in Type 2 Diabetes”. Chapter 4, “Evaluating the
Use of a Best Practice Guideline with Insulin Initiation in Type 2 Diabetes” presents findings for
questions #3 and #4.

1.4 Research Approach
The theory to frame this study was Lazarus and Folkman’s (1984) cognitive theory of stress and
coping. The theory provides a framework for examining psychological stress and holds that
stress is contextual, an interaction between the person and his/her environment. Folkman (1997)
further revised the model to include positive psychological states. As defined by Lazarus and
Folkman, stress is “a relationship between the person and the environment that is appraised by
the person as taxing or exceeding his or her resources and endangering his or her well-being”
(Lazarus & Folkman, 1984, p. 21). Stress is not considered to be static and is purported to
change over time as a result of interaction between the individual and their environment.
The definition of coping depends on the theoretical framework or context in which coping is
identified. Coping is described as a dynamic system which is highly interactive (Folkman,
2010). Coping varies amongst individuals based on the “intensity of their emotion response and
their ability to regulate it, the opportunities inherent in the situation for problem solving, and
changes in the person-environment relationship as the situation unfolds” (Folkman & Greer,
2000, p. 13). This statement regarding coping is consistent with Bandura’s conceptualization of
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coping, his view being that a person’s beliefs in their coping capabilities can affect the level of
stress experienced in threatening or difficult situations (1994).
The hypothesized relationships between the study variables: RNAO BPG education, stress,
coping, and self-efficacy with initiation of insulin therapy are illustrated in Figure 1.

1.5 Method
A pretest / posttest, non-experimental design was undertaken using one group of participants.
Participants were insulin and injection therapy naïve. Convenience sampling was used to obtain
a final sample size of 105, calculated to provide a medium effect size of 0.15, an alpha error
probability of 0.05 and a power calculation of 0.80 assuming a 10% withdrawal or failure to
complete study rate. Participants’ stress scores were measured with the following validated
tools: Perceived Stress Scale (Cohen, Kamarck, & Mermelstein, 1983). Coping (ways of
coping) was measured with the WAYS questionnaire (Folkman & Lazarus, 1988). The
Confidence in Administering Insulin-Managing Diet Scale questionnaire developed specifically
for use with the RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type
2 Diabetes was utilized to measure participants’ insulin therapy self-efficacy (B. Davies et al.,
2006). A BPG evaluation tool developed by the author for this study measured participants’
recall of the BPG contents. Participants were surveyed just prior to beginning insulin therapy
and then approximately six weeks following initiation of insulin therapy at scheduled
appointments at a Diabetes Education Centre (DEC).
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Descriptive and inferential analyses were performed using the IBM SPSS Statistics v. 22 (IBM.,
2013). Paired-samples t-tests and a mediated regression analysis were undertaken to answer the
research questions. Content analysis was utilized to examine qualitative data obtained from the
BGP evaluation tool.

1.6 Integrated Thesis Article Format
This dissertation is structured in the integrated article format as regulated by the School of
Graduate and Postdoctoral Studies at Western University, London, Ontario. Chapter 1 provides
an introduction of the foundations for the dissertation research. Chapters 2, 3, and 4 are
independent, original articles submitted for publication in peer-reviewed journals relevant to the
content of each article. Chapter 5 provides an integrated summary of the dissertation work.
Chapter 2, ‘Stress and Coping in Patients with Type 2 Diabetes Initiating Insulin: A Scoping Review’
This is the first of three articles for publication. This scoping review was undertaken to map the
literature, sources of evidence, and gaps in the published research related to stress and coping
when patients initiate insulin therapy. Literature between 2001 and 2013 was reviewed. Policy
mapping was included within the scoping review to identify documents and statements from
professional bodies that influence the nature of practice within the speciality of diabetes.
Additionally policy mapping was done to identify educational strategies currently in place and
offer direction for future educational strategies. The selection process of identifying relevant
studies resulted in nine items that most closely aligned with the research questions and nine
documents that related to the policy mapping.
Two themes emerged from the scoping review (a) insulin initiation barriers and (b) coping. The
findings reinforced the importance of the psychological aspect of diabetes care which can be
critical for successful self-management of diabetes especially for patients requiring insulin
therapy. The policy mapping identified comprehensive evidence-based clinical practice
guidelines and policy frameworks available as resources for diabetes care. More importantly,
there was increasing evidence of integration and recognition of the psychological elements of
diabetes care into these resources.
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Chapter 3, ‘Coping as a Mediator of Stress with the Initiation of Insulin in Type 2 Diabetes’
The second article presents the results of the data analysis of the study variables perceived stress,
ways of coping, and insulin initiation self-efficacy. A final sample was obtained from three
independent Diabetes Education Centres (N = 105). For research question #1, What is the
relationship between perceived stress and education guided by the RNAO BPG for Subcutaneous
Administration of Insulin in Adult Patients with Type 2 Diabetes?, there was a statistically
significant (p < 0.05) decrease in the pretest to posttest scores for perceived stress and increase in
scores for insulin self-efficacy. Results showed that patient stress decreased and insulin selfefficacy increased after receiving the RNAO BPG insulin initiation education.
Question #2, What is the relationship between perceived stress, ways of coping and the initiation
of insulin therapy in adults with type 2 diabetes? This question was analyzed using mediated
regression and correlations. The correlational analysis revealed a moderately positive correlation
between stress and coping and a weak, inverse correlation between stress and insulin initiation
self-efficacy. The relationship between coping and insulin initiation self-efficacy was nonsignificant.
The mediated regression analysis examined the relationship between perceived stress and insulin
initiation self-efficacy with coping as a mediator. A bias-corrected bootstrap estimate of the
95% confidence interval for the indirect effect of coping indicated that coping was a mediator of
the relationship between perceived stress and insulin initiation self-efficacy.
The results of this study suggested assessment of stress and coping would be beneficial for
patients initiating insulin therapy. The RNAO BPG can be used by diabetes clinicians to initiate
insulin therapy with structured education assisting patients to attain self-efficacy with insulin
therapy with a decrease in their stress levels.
Chapter 4, ‘Evaluating the Use of a Best Practice Guideline with Insulin Initiation in Type 2
Diabetes’
The third article of this dissertation discusses patient recall of diabetes education with the use of
the RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes
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and an evaluation tool that was developed for use with this BPG. Best Practice Guidelines are
becoming increasingly integrated into nursing care and provide a synthesis of research and
clinical expertise. Results are presented for Question #3, What is the level of participant recall of
diabetes education using the RNAO BPG for the Subcutaneous Administration of Insulin in
Adults with Type 2 Diabetes as evaluated by a novel BPG evaluation tool? and Question #4,
What is the patient experience of initiating insulin therapy when receiving structured Best
Practice Guideline diabetes education?
The results of this study demonstrated effective provision of the RNAO BPG with participants
recalling 80% of the BPG content. Sick day management items, however, had a noticeably
lower rate of recall at 27% – 62%. This is an area for further research as the potential for
significant patient harm can result during illness, for example, with poorly managed insulin
dosing or if patients become severely dehydrated. Lack of knowledge to self-manage routine
illnesses may require patients to seek intervention from their primary care provider or in severe
cases patients may need to access urgent care or emergency room assessment which has
implications within the context of today’s fiscally challenged healthcare environment.
The RNAO BPG evaluation tool developed for this study required the deletion of one item to
yield a measurement scale with an acceptable internal consistency i.e. a Cronbach’s alpha of
greater than or equal to 0.70.
Content analysis performed on participant responses to three open-ended questions: 1. “Please
describe how you felt when you were asked to start using insulin”, 2. “What was the most
challenging thing about starting insulin?”, and 3.”What made it easier to start using insulin?”
revealed three distinct categories of responses. Consistent with the literature were responses
related to the first category labeled as Psychological Insulin Resistance (PIR). Participant
responses identified the emotional elements related to insulin initiation such as fear of needles or
injection, anxiety, or a belief that their diabetes is worsening. The second category was labeled
Knowledge Deficit and reflected participants’ misconceptions of current diabetes management.
This has also been identified in the literature. The last category was labeled Education Impact.
Responses in this category supported the positive impact of the education they received which
was guided by the RNAO BPG for the Subcutaneous Administration of Insulin in Adults with
Type 2 Diabetes.
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1.7 Summary
The final chapter presented in the thesis is an integrated summary of the research findings as
identified in the three articles included in this dissertation. The examination of the relationship
between perceived stress and education guided by the RNAO BPG is reviewed. The need for
further research into the psychological assessment of patients initiating insulin therapy is
discussed. The development and utilization of the RNAO BPG evaluation tool are examined to
assist with further revision of the tool for future use. The results of the examination of the
relationship between perceived stress, ways of coping and insulin initiation self-efficacy provide
a foundation for continuing research to explore coping and stress in patients initiating insulin
therapy. The discussion includes patient focused assessment and exploration of educational
strategies that best meet the needs of this unique patient population. Implications for nursing and
future research are reviewed.
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Chapter 2
2

Stress and Coping in Patients with Type 2 Diabetes
Initiating Insulin: A scoping review

2.1 Introduction
The global burden and incidence of type 2 diabetes is increasing precipitously in countries all
over the world (International Diabetes Federation, 2013). In 2013, approximately 2.6 million
Canadians were living with diabetes (type 1 or type 2). The majority of people, 90 to 95% have
type 2 diabetes which is a combination of insufficient insulin production and impaired response
to insulin’s effects (insulin resistance) (Public Health Agency of Canada, 2011a).

(Despite

healthcare provider efforts and the integration of clinical practice guidelines, approximately half
of the Canadians living with type 2 diabetes do not achieve the glycemic target of hemoglobin
A1C < 7.0% (Harris, Ekoe, Zdanowicz, & Webster-Bogaert, 2005; Harris, Kapor, Lank,
Willan, & Houston, 2010b; Leiter et al., 2013b). Optimal glycemic control is critical for the
prevention or minimization of diabetes-related complications as demonstrated by the landmark
United Kingdom Prospective Diabetes Study (United Kingdom Prospective Diabetes Strategy
(UKPDS) Group, 1998). Diabetes self-management education (SME) has been shown to
provide clinically important benefits for patients with type 2 diabetes including hemoglobin A1C
reductions (Jones, Berard, MacNeill, Whitham, & Yu, 2013). With the number of people living
with diabetes projected to rise significantly in the next 20 years, educating patients regarding
self-management is critical to ensure their quality of life and avoidance of complications. This is
particularly relevant in a healthcare system where fiscal pressures are evident and economic
burden of diabetes in Ontario in 2010 was 4.9 billion dollars (Canadian Diabetes Association,
2013b).
In order to achieve optimal glycemic control, many patients with type 2 diabetes will require
insulin. The use of insulin, which historically was often the last agent to be added to a patient’s
treatment, is now considered at any stage of the diabetes continuum according to the Canadian
Diabetes Association (CDA) Clinical Practice Guidelines based on the patient’s clinical
presentation. Barriers to insulin therapy such as psychological insulin resistance (PIR), diabetes
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distress, and clinical inertia are well documented in the literature (Brod, Kongso, Lessard, &
Christensen, 2009; Brown, Nichols, & Perry, 2004; Fisher et al., 2009; Gherman et al., 2011;
Harris, et al., 2010a; Harris, Yale, Dempsey, & Gerstein, 2008; Paddison, Alpass, & Stephens,
2007; Peyrot et al., 2005; Polonsky, 2007). This presents a challenge for healthcare providers
working with patients to help them to achieve optimal glycemic control and enhanced quality of
life. Recognizing that self-management education needs to be tailored to meet individual needs,
it is imperative that healthcare providers have an understanding of patients’ perspectives of their
diabetes and the factors influencing their abilities for diabetes self-management. Only then can
educational strategies and clinical practice guidelines fully reflect the holistic needs of patients
and appropriately inform the healthcare providers working with these patients. The purpose of
this scoping review is to provide a descriptive account of available research and non-research
material centring on the research gap associated with patients starting insulin therapy with type 2
diabetes. A scoping review was chosen for the ability to map the literature, sources of evidence,
and gaps in the research particularly when “there is suspicion that not enough literature exists”
and “further primary research is necessary” (CIHR, 2009).

2.1 Method
A scoping review based on the framework proposed by Arksey and O’Malley (2005) was chosen for
this article. The framework identifies five stages with an optional consultation exercise:
(1) Identifying the research question.
(2) Identifying relevant studies.
(3) Study selection.
(4) Charting the data.
(5) Collating, summarizing and reporting the results.
(6) Optional consultation exercise
Arksey and O’Malley suggest a common reason for the use of a scoping review includes
identifying research gaps in the current literature which aligns well with this review. Anderson,
Allen, Peckham, and Goodwin (2008) suggest policy mapping as a scoping review can identify
main documents and statements from professional bodies that influence the nature of practice in
that area. This element was included in this scoping review to assist with guiding future
educational strategies.
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The research question for this review was “What is known about the relationship between
perceived stress, ways of coping and the initiation of insulin therapy in adults with type 2
diabetes?” A policy mapping was also included as part of this review to examine the main
documents and statements available that relate to the nature of practice in this area of diabetes.
In order to identify relevant literature, electronic database searches were performed in
CINAHL, PubMed, PyschINFO, and ProQuest. The main subject areas searched were diabetes,
stress, coping, and diabetes health policy. Websites for organizations known to have a strong
focus in diabetes care were searched directly for any policy or guideline statements. As there is
no worldwide common database for grey literature, the search strategy included primarily North
American literature. The focus of the search was based on type 2 diabetes particularly in relation
to the initiation and the use of insulin. For this review, stress was defined as the relationship
between a person and the environment which affects the person’s well-being. The definition of
coping used for this review was the thoughts and behaviours used by a person to manage stress.
Search terms used independently and then in combination included: diabetes mellitus, type 2
diabetes, diabetes self care, coping, ways of coping, stress, distress, psychological distress,
insulin, initiating insulin, starting insulin, psychological insulin resistance. Inclusion criteria for
this scoping review were: (a) English language, (b) primary research, meta-analysis, literature
review, and (c) published between 2001 and 2013. Reference lists of selected items were hand
searched for additional items eligible for inclusion in the review. To complete the policy
mapping review, a grey literature search of North American diabetes professional organizations
and governmental bodies focused on diabetes clinical practice documents.
The selection process resulted in nine relevant items that most closely aligned with the
research question and nine documents related to policy mapping. It is important to remember
that, unlike a systematic review, a scoping review can include a range of different methods and
study designs and does not assess the quality of evidence, rather it provides a descriptive account
of available research (Arksey & O'Malley, 2005). Although there was an abundance of literature
on the separate elements of the research question, stress or coping with type 2 diabetes or
guidelines detailing suggested processes for initiating insulin, more difficult to find were articles
which included all of the elements of the research question. Few items were focused specifically
on stress and ways coping at initiation of insulin therapy. Charting the data for a scoping review
involves extracting data using a “narrative review” method which presents contextual or process
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oriented information from each item included in the review (Arksey & O'Malley, 2005; Levac,
Colquhoun, & O'Brien, 2010). The data from this review were organized along two thematic
categories (a) Insulin initiation barriers and (b) Coping (Table 1). The data from the policy
mapping were charted according to the regional level of policy influence (Table 2).
Table 1 Selected Scoping Review Items
Author/Date/Country Method / Aim

Sample

Important Results

Insulin Initiation Barriers

Bogaten & Hancu

Qualitative semi-

n = 18 people

Psychological Insulin Resistance

2001

structured interviews

at the moment

(PIR) influenced by the

Romania

with phenomenologic

of initiating

perceived reasons for the need

and content analysis

insulin therapy

to start insulin therapy and the

Aims: (1) Identify

perceived consequences of

representations of

insulin therapy

insulin therapy, (2)
study the factors

Patient attitudes regarding

influencing the

insulin therapy influenced by

representations, (3)

family, healthcare providers,

study factors that

others on insulin

might influence
decision to

Physical discomfort is a

accept/refuse

determinant factor in

treatment

acceptance/refusal of insulin
therapy

Gherman et al.,

Critical Literature

n = 60 varied

PIR consistent among insulin

2011

Review

articles

naïve patients with ~ 27%

Romania

Aim: Answer the
questions: How is
PIR measured? With

refusing to initiate insulin
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what instruments?

Emotional state, lack of

Predictive factors?

knowledge, low self-efficacy

Interventions

predictors of PIR

proposed to reduce
PIR?

Relationship with healthcare
providers influences PIR

Polonsky, Hajos,

Internet survey

n = 1400

Presence of PIR common across

Dain, Snoek

Aim: Assess

insulin-naïve

the 8 Western nations with

2011

willingness to start

patients with

17.2% unwilling to and 34.7%

U.S.A.

insulin, insulin

type 2 diabetes

ambivalent about starting

beliefs, current

in 8 Western

insulin

medications, diabetes

nations

distress

Patients unwilling or ambivalent
to start insulin reported more
diabetes-related emotional
distress

Authors suggest most effective
approach to PIR involves
addressing patients’ emotional
distress

Rubin, Peyrot,

Internet surveys

Provider

Reported several findings

Kruger, Travis

Provider survey

sample

related to the burden of insulin

2009

(physicians, diabetes

n = 301

injections e.g. 46% patients

U.S.A.

educators)

Patient sample

have changed their life to avoid

Patient self-report

n = 501 with

extra injections

Aim: Compare

77% of

patients’ perceptions

patients having Moderate or major impact of

of injection-related

type 2 diabetes

insulin injections on quality of
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problems with

life reported by 14% of

clinicians’ estimates

patients

of those problems
Healthcare providers report
highest impact of problems for
adherence to injections related
to anxiety

Wang & Yeh

Mixed-methods

n = 16 studies

15 descriptive themes – 3 of

2012

systematic review

with 7961 total

which focused on participants’

Taiwan

Aim: Describe the

participants

choices of how to cope 5 main

phenomenon of PIR

theme categories with two levels

from the perspective

– cognitive appraisal and

of adults with type 2

emotional responses

diabetes
Coping
Gafvels & Wandell

Cross sectional design

n = 232

Coping strategies clearly

2005

– self-report coping

patients ~ 30%

associated with metabolic

Sweden

questionnaire; chart

on insulin

control.

review

Variations in coping strategies

Aim: Assess and
compare coping
strategies in patients
with type 2 diabetes

between men and women.
Coping a good predictor for
HbA1C and microangiopathy.

Karlsen, Oftedal,

Cross sectional design

n = 378 adults

One fifth of participants

Bru

- questionnaires

with 28.6% on

experienced relatively high

2012

Aim: Describe

insulin

levels of diabetes-related

Norway

diabetes-related

distress

distress, coping styles,

Greater variance in emotional

perceptions of social

distress accounted for by

support among adults

coping styles and perceived
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with type 2 diabetes

support versus clinical
indicators

Healthcare providers should
develop methods to decrease
diabetes-related distress that
prevent the use of negative
coping styles

Macrodimitris &

Cross-sectional design n = 115 adults

Problem-focused coping related

Endler

- 4 measures

with 18.3% on

to better psychological

2001

Aim: determine

insulin

adjustment

Canada

relationships among
coping, illness

Emotional preoccupied coping

control, psychological

and avoidance coping related

adjustment

to poor psychological
adjustment

Shah et al.

Cross-sectional design n = 201 adults

Patients who experienced

2012

using cognitive and

with 35.3% on

greater diabetes-related stress

U.S.A.

behavioural coping

insulin

had a negative appraisal of their

strategy instrument

diabetes and were less likely to

and a screening tool

use problem-focused coping

for depression
Aim: Examine the

Emotions and coping play a

relationship among

central role in the

diabetes-related

diabetes/depressive symptom

distress, appraisal,

relationship

coping and depressive
symptoms
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2.2 Results
Arksey and O’Malley (2005) describe the fifth stage of the scoping framework as collating,
summarizing and reporting the results. The following overview describes the two themes
identified within this scoping review and the results of the policy mapping. The results are
divided into three subsections. The two themes identified were (1) insulin initiation barriers, and
(2) coping. The final subsection describes the results from (3) policy mapping.

2.2.1 Insulin Initiation Barriers
Five of the articles selected for this scoping review reflected the theme identified as “insulin
initiation barriers”, given that the majority of literature examines issues that impede insulin
initiation. Psychological insulin resistance (PIR) is the dominant concept throughout this area of
the literature and is most often defined as a psychological (cognitive, emotional, relational, and
cultural) barrier or opposition to the initiation of insulin (Brod, et al., 2009). Diabetes-related
distress is also found within this theme and is defined as the disease specific stress related to the
burden of self-care management of diabetes. The articles selected included one qualitative study,
one literature review, two internet surveys and a mixed-methods systematic review.
Bogatean and Hancu (2001) conducted a qualitative study using semi-structured interviews
with 18 participants (11 men, 7 women) at the moment of initiating insulin. A phenomenologic
analysis and content analysis revealed that psychological insulin resistance is influenced by the
perceived reasons of the need to start insulin and the perceived consequences of insulin therapy.
Findings also revealed that attitudes regarding insulin therapy are influenced by family, other
people on insulin, and the healthcare team.
Gherman et al. (2011) performed a critical literature review of psychological insulin
resistance (PIR) and the strategies to reduce it. Databases were searched ultimately yielding 60
articles of varying types (reviews, editorials, cross-sectional studies, instrument validation) that
were summarized in the meta-analysis. Six instruments were found that investigated the
emotional distress related to insulin, positive/negative insulin expectations, or satisfaction with
consequences on daily activities. The authors found that the number of patients with PIR in
research settings versus community settings is consistent at approximately 27%.

Themes

revealed emotional states influenced PIR, as well as, cognitive predictors, e.g., lack of
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knowledge. Healthcare providers were found to have an influence on a patient’s perception of
requiring insulin.
In a multi-national study to examine the perceptions of insulin-naïve type 2 diabetes patients,
Polonsky, Hajos, Dain and Snoek (2011) found the presence of psychological insulin resistance
(PIR) to be common. Participants originated from France, Germany, the United Kingdom, Italy,
the Netherlands, Spain, Sweden, and the U.S.A. with a sample size of 1400. Qualitative
interviews were conducted to develop survey tools assessing beliefs about insulin, beliefs about
current oral medications, and diabetes-related distress. Findings showed patients unwilling or
ambivalent to start insulin reported more diabetes-related emotional distress replicating results
from previous studies (Makine et al., 2009; Snoeks, Skovlund, & Pouwer, 2007). The authors
suggest the most effective approach overall to overcoming or preventing PIR includes addressing
emotional distress about living with diabetes, worries about diabetes medicines and patients’
specific beliefs about insulin.
Barriers to injection therapy were compared in a study by Rubin, Peyrot, Kruger, and Luther
(2009). They described the (1) burden of insulin injections, (2) impact of injections on quality of
life, (3) impact of injection therapy on treatment adherence, (4) injection-related patient/provider
communication, and (5) tools to ease burden of insulin injections. Overall, a substantial
majority of patients wanted to reduce the number of injections they took on a daily basis. More
than half of the patients indicated that they were more likely to take their insulin injections if a
product was available to ease the pain of injection.
In a mixed-method systematic review of psychological insulin resistance (PIR) in adults with
type 2 diabetes the authors concluded that there is impact from a range of cognitive and/or
emotional reaction personal viewpoints (Wang & Yeh, 2012). The review question was “What is
known about the psychological barriers to starting insulin therapy among adults with T2DM
when or if their physicians recommend they use insulin therapy?” The sixteen articles reviewed
originated from sixteen developed countries with participants from Europe, Asia, Australia, and
North America. Seven of the studies were interview models, five were descriptive studies and
four performed psychometric analyses of data related barriers to insulin initiation. The five main
themes reported that people with type 2 diabetes (1) do not see the necessity for insulin and
actively seek ways to control blood sugars without insulin, (2) have a holistic view of the
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consequences of insulin, (3) see insulin therapy as less feasible, (4) see insulin as a source of
fear/anxiety, and (5) feel the necessity to start insulin therapy has a very negative connotation
and is associated with dysfunctional emotions. The authors concluded that psychological
resistance to insulin therapy involved cognitive appraisal and emotional reaction requiring
assessment of an individual’s psychosocial barriers to insulin therapy.

2.2.2 Coping
Four cross-sectional studies were identified in the second theme identified as coping. Gafvels
and Wandell (2006) conducted a cross-sectional study assessing coping strategies with a
Swedish, non-illness specific, self-report questionnaire measuring cognitive, emotional, and
action-orient coping efforts. Demographic data was collected from medical records and data on
social and psycho-social background were taken from a previous study. Main study findings
reported a clear association between coping strategies and metabolic processes. Differences in
coping strategies found women using negative coping methods (resignation, protest, isolation)
more often than men. Coping was found to be a good predictor for hemoglobin A1C and
microangiopathy in insulin treated patients.
The study that most reflected the research question of this scoping review was conducted by
Karlsen, Oftedal and Bru (2012). The cross-sectional design employed questionnaires to
investigate clinical indicators (hemogloblin A1C, complications, BMI, disease duration), coping
styles, and perceived support from healthcare professionals and family related to diabetes-related
distress. Of 689 participants invited to participate, a final sample size of 378 was obtained. The
Problem Areas in Diabetes (PAID) instrument was utilized to assess diabetes emotional distress,
sub-scales from the COPE Inventory and Ways of Coping Questionnaire assessed coping styles.
The Patient Questionnaire on Empowerment assessed support from healthcare providers, while
the Diabetes Family Behaviour Checklist assessed family behaviours. The authors reported that
one-fifth of the participants reported severe diabetes-related distress which was consistent with
previous research (Fisher, et al., 2009). Also consistent with previous research, was the finding
that showed greater use of task-oriented coping more than emotion-focused coping. Participants
felt they received constructive support to a much greater degree from healthcare providers (76%)
than their families (11%). The regression analysis showed a substantially greater variance in
emotional distress accounted for by coping styles and perceived support versus clinical
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indicators. The authors suggested that healthcare providers should develop methods to decrease
diabetes-related distress that prevent the use of negative coping styles.
The only Canadian study selected for this scoping review was a cross-sectional design
investigating the relationships of coping strategies and perceived control to psychological and
physiological adjustment in adults with type 2 diabetes (Macrodimitris & Endler, 2001).
Separate instruments were used to assess the following variables (1) coping, (2) perceived
control, (3) anxiety, (4) depression, and (5) hemoglobin A1C. Findings indicated that problemfocused coping strategies were related to better psychological adjustment, while in contrast,
emotional coping and avoidance coping were related to higher depression and state anxiety.
Perceived control was determined to have a direct negative relationship to depression, state
anxiety and hemoglobin A1C. The authors suggested that high levels of perceived control have a
favourable effect on adjustment in people with type 2 diabetes.
The relationship between diabetes-related distress, appraisal, coping and depressive symptoms in
adults with type 2 diabetes was examined in the context of the transactional model of stress and
coping by Shah, Gupchup, Borrego, Raisch, and Knapp (2012). A sample of 201 participants
completed the cross-sectional study which utilized surveys and a medical records chart review.
Findings revealed that participants with depressive symptoms reported significantly higher levels
of diabetes-related stress than patients without depressive symptoms. Findings also suggested
that appraisal was a mediator in the relationship between stress and coping. Appraisal also
mediated the relationship between depressive symptoms and the coping measures of avoidance,
passive resignation, and diabetes integration. The authors suggest emotions and coping play a
central role in the relationship between diabetes and depressive symptoms and that interventions
that promote stress management and healthy coping may assist patients to adapt to living with
diabetes.

2.3 Policy Mapping
The policy mapping element of this scoping review focused on the main documents and
statements from professional bodies that influence the nature of clinical practice in diabetes. The
nine documents published in English selected for this scoping review originated from developed
countries that possess the resources and expertise to provide diabetes care at a similar level. The
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countries represented within this policy mapping review are congruent with the sources of items
selected for the previous section related to the research question scoping review. Six of the
documents are directed at healthcare providers with evidence-based clinical practice guidelines
to direct care of individuals with type 2 diabetes (American Diabetes Association, 2014;
Canadian Diabetes Association, 2013a; International Diabetes Federation, 2012; National
Collaborating Centre for Chronic Conditions, 2008; Registered Nurses Association of Ontario,
2009; Ryden et al., 2013). Practice guidelines directed at diabetes educators provide guidance
for the training of diabetes educators and diabetes educational practice in the United States
(American Association of Diabetes Educators, 2011) The National Service Framework for
Diabetes (Department of Health (United Kingdom), 2001) was developed to provide direction
for diabetes care in health sector service planning in the United Kingdom. Similarly, The
Diabetes in Canada (2011) document is a statistical resource to support public health
professionals and organizations in the development of evidence-based public health policies and
programs in the prevention and management of diabetes. The policy mapping documents are
summarized in Table 2.

Table 2 Policy Mapping Results
Source/Year

Policy

Document

Summary

Guidelines for the Practice

Clarifies the roles and

Diabetes Educators

of Diabetes Self-

responsibilities of all

(AADE)

Management Education

persons facilitating

2011

and Training

diabetes education

Clinical Practice

Evidence-based

Recommendations

clinical practice

Influence
Level
American Association of

American Diabetes
Association

National

National

(ADA)

recommendations to

2014

be interpreted on an
individual basis
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Canadian Diabetes

National /

Clinical Practice

Provides evidence-

Association

International

Guidelines for the

based

(CDA)

Prevention and

recommendations on

2013

Management of Diabetes

screening, prevention,

in Canada

diagnosis, education,

Chapters 1, 7 , 9, 13

care and management
of diabetes.

Department of Health

National

National Service

Standards, rationales,

(United Kingdom)

Framework for Diabetes:

key interventions,

2001

Standards

implications for
planning services

European Association

International

ESC Guidelines on

Guidelines provide

for the Study of Diabetes

diabetes, pre-diabetes, and

educational tool with

(EASD) in collaboration

cardiovascular diseases

evidence-based

with European Society

developed in collaboration

approaches and

of Cardiology (ESC)

with the EASD

algorithms for

2013

achieving best care in
managing the
combination of
diabetes and
cardiovascular disease

International Diabetes

International

Federation

Global Guideline for Type

Clinical practice

2 Diabetes

guideline sensitive to

(IDF)

resource and cost-

2012

effectiveness issues
for countries with
limited resources
(expertise, financially)

National Institute for

National

Type 2 Diabetes

Clinical, evidence-
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Health and Clinical

National clinical guideline

based guidelines

Excellence (NICE)

for management in

intended for

(England and Wales)

primary and secondary

healthcare

2008

care

professionals, people
with type 2 diabetes
and their support
systems

Registered Nurses

Provincial /

Best Practice Guidelines

Provides resources

Association of Ontario

National

directed at diabetes

necessary for the

(RNAO)

(a)Subcutaneous

support of evidence-

2007-2013

Administration of Insulin

based nursing practice

in Adults with Type 2

in the provision of

Diabetes 2009

individualized care.

(b)Assessment and
Management of Foot

Provides overview of

Ulcers for People with

structures and

Diabetes 2013

supports necessary for

(c) Reducing Foot

provision of best

Complications for People

possible evidence-

with Diabetes 2007

based care

Diabetes in Canada: Facts

Provides most recent

Canada

and figures from a public

diabetes statistics in

2011

health perspective 2011

Canada. Offers risk

Public Health Agency of

National

factors for developing
diabetes

2.4 Discussion
The findings from this scoping review reinforce the need for continued research exploring the
psychological aspects of diabetes care which is integral to helping patients improve their diabetes
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self-management and ultimately their glycemic control. Despite the availability of extensive
clinical practice resources, new pharmacologic agents, and an increased awareness of the
psychosocial needs of patients with diabetes, the majority of patients do not reach target
glycemic control (Nam, Chesla, Stotts, Kroon, & Janson, 2011; Nicolucci et al., 2013a; Piya,
Tahrani, & Barnett, 2010). In a recent follow-up to a major research study exploring the
Diabetes Attitudes, Wishes, and Needs (DAWN) of people with diabetes, the need for
psychosocial support and individualized education was once again reinforced (Holt et al., 2013;
Nicolucci et al., 2013b; Peyrot, et al., 2005). The two themes identified in this scoping review:
(a) insulin initiation barriers and (b) coping, elucidate the importance of examining these
concepts from the individual’s perspective. It is critical that healthcare providers design and
deliver educational supports that will meet the needs of the individual.
Foundational research exists which examines the barriers to insulin initiation. Numerous factors
have been identified from both the patient and healthcare provider perspectives. These factors
include psychological insulin resistance, diabetes distress, fear of injection therapy, and clinical
inertia. As Wang and Yeh (2012) suggest, technique-oriented skills training or endeavouring to
convince individuals to initiate insulin therapy, may meet the needs of the healthcare provider
but not those of the individual. They further suggest, “It is essential to have knowledge of how
people arrive at medical decisions in relation to their perception of the illness, before we can
guide people’s awareness of the need for insulin therapy” (p. 754). Previous research (Bogatean
& Hancu, 2001) reported patient attitudes regarding insulin are influenced by their family, others
on insulin, and healthcare providers which means that the opportunity to educate and influence
patients exists. The key is for healthcare providers to use their opportunity to educate in a way
that is meaningful for the patient. With the research by Polonsky, Hajos, Dain and Snoek (2011)
demonstrating that psychological insulin resistance (PIR) is a common phenomenon, both
researchers and educators should heed the authors’ suggestion that the most effective approach to
decrease PIR is by addressing patients’ emotional distress.
Mirroring the need for further research regarding stress and distress, the concept of coping
continues to receive increasing focus. The findings of Gafvels and Wandell(2006) linking coping
strategies to glycemic control reiterated the link between the psychological and biophysical
aspects of diabetes. Shah et al. (2012) concluded that the knowledge that patients with high
stress levels are likely to develop a negative appraisal of their diabetes, should assist educators to

26
develop programs for those at high risk. They also assert that stress management training could
be incorporated in diabetes education programs. This reinforces the need for individualized
patient assessment with a goal of comprehensive, holistic care.
Research has established that patients employ varying coping styles. Coping styles such as
behavioural disengagement and self-blaming are linked significantly with emotional distress
(Karlsen, et al., 2012) (Canadian Diabetes Association, 2013c). For those patients who have
difficulty with their diabetes self-management, an understanding of their coping styles could
assist healthcare providers when choosing educational strategies and processes for providing
care.
Comprehensive practice guidelines and policy frameworks are available as evidence-based
resources in diabetes. As the research evidence continues to accumulate regarding the
importance of the psychological aspects of diabetes care, it is encouraging that diabetes
professional organizations and makers of health policy are integrating these elements into the
practice guidelines and frameworks that guide diabetes care. Chapters addressing the
psychological care of individuals with diabetes can be found in the clinical practice guidelines
from Canada, United States, United Kingdom, Europe and the International Diabetes Federation.
The documents selected within the policy mapping for this scoping review, consistently
identified the need to provide comprehensive diabetes care while acknowledging that continued
research is required. Although the need for psychological support is articulated in practice
guidelines, knowledge translation is sub-optimal as gaps persist in our understanding of patient
perceptions of diabetes and their ways of coping.

2.5 Conclusion
This scoping review highlights the paucity of knowledge available to inform healthcare providers
of the patient’s perception of stress and coping with the initiation of insulin therapy and therefore
a gap in research knowledge. (Figure 2) Evidence continues to mount highlighting the
importance of addressing these psychological aspects of diabetes care. The challenge to
researchers and healthcare providers is to identify these influencing factors and incorporate
educational strategies that acknowledge these factors. Patient-specific education strategies
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recognizes the unique challenges that each patient faces and may assist patients to meet their
goals of self- care with the hopes of improving glycemic control and enhancing quality of life.
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Figure 2

Research Question
What is known about the
relationship between
perceived stress, ways of
coping, and the initiation of
insulin in patients with type 2
diabetes?

Themes Identified
and
Research Implications

Policy Mapping Results

Insulin Initiation Barriers

Coping

Psychological insulin
resistance, found in both
patients and health care
providers

Coping strategies are
associated with metabolic
control and can be influenced
by stress

Large body of research exists
elucidating this concept with
calls to further explore the
emotional elements for
patients

Paucity of research looking at
a link between stress and
coping when initiating insulin
therapy in type 2 diabetes and
the implications for patient
education

Majority of agencies provide
evidence-based clinical
practice guidelines to guide
health care providers
identifying the importance of
patient-focused care
Results demonstrate a
common theme of patientcentred care and education
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Chapter 3
3.

Coping as a Mediator of Stress with the Initiation of Insulin in
Type 2 Diabetes

3.1 Introduction
Type 2 diabetes affects approximately 90% of those who live with diabetes (Centre for Disease
Control and Prevention, 2014; Government of Canada, 2013) . In Canada, an estimated 2.6
million people live with this disease and in every age group, individuals with diabetes have
mortality rates at least two times higher than those without diabetes (Public Health Agency of
Canada, 2011b). For a chronic, progressive disease, the focus of diabetes patient education is to
provide the knowledge and skills that will allow patients to self-manage their condition and
minimize the potentially devastating complications of diabetes. People living with diabetes are
at increased risk for macrovascular complications (myocardial infarction and stroke) and
microvascular complications (retinopathy, nephropathy, neuropathy) (Chalmers & Cooper, 2008;
Lasker, 1993; United Kingdom Prospective Diabetes Strategy (UKPDS) Group, 1998). Glycemic
targets and clinical practice guidelines for the management of diabetes continue to evolve as
research demonstrates the importance of optimal glycemic control (Chalmers & Cooper, 2008;
Holman, Paul, Bethel, Matthews, & Neil, 2008; United Kingdom Prospective Diabetes Strategy
(UKPDS) Group, 1998). The 2013 Canadian Diabetes Association Clinical Practice Guidelines
emphasized the importance of achieving optimal glycemic control within 3 to 6 months once
pharmacologic therapy has been initiated. The guidelines also suggest that patients with marked
hyperglycemia may benefit from the initiation of insulin as a first line intervention in addition to
oral agents (Harper et al., 2013).
Clinical practice has historically reserved the use insulin as one of the final agents to be added to
a patient’s pharmacologic regimen. This hesitation may be in part related to the phenomenon
known as psychological insulin resistance (PIR). Psychological insulin resistance is most often
defined as a psychological barrier or opposition to the initiation of insulin (Brod, et al., 2009;
Gherman, et al., 2011; Polonsky, 2007). PIR is well documented in the literature and is found
within both patients and healthcare providers. Patients are reluctant to start or fear beginning
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insulin therapy and clinicians are reluctant to initiate insulin therapy. The reluctance by clinicians
to initiate insulin therapy is more specifically termed “clinical inertia” (Brown, et al., 2004;
Harris, et al., 2010b; Harris, et al., 2008; Phillips et al., 2001). Unfortunately, delaying the
introduction of insulin has sometimes been leveraged by healthcare providers as a motivator for
patients to improve their adherence to lifestyle and dietary changes reinforcing the idea that
insulin should be left as the last resort. This “treatment to failure” approach – adding multiple
oral agents with insulin as the final option- is challenged in the literature as unnecessarily
prolonging an uncontrolled hyperglycemic state in patients predisposing them to the
microvascular and macrovascular complications of diabetes (DeFronzo, Eldor, & Abdul-Ghani,
2013; Lingvay et al., 2009).

3.1.2 Stress and Diabetes
The psychosocial aspects of living with diabetes are well recognized (Clement, et al., 2013;
Jones, et al., 2013; Nicolucci, et al., 2013b; Peyrot, et al., 2005; Skovlund & Peyrot, 2005).
Managing diet and exercise, self-monitoring of blood glucose, and adhering to medication
regimens on a daily basis often create a heavy burden for those living with diabetes. Diabetes
distress describes the disease-specific stress related to this burden of diabetes self-care
management. The challenges with the identification and treatment of diabetes distress are also
well described in the literature (Fisher, et al., 2009; Paddison, et al., 2007; Peyrot, Rubin, &
Siminerio, 2006). Research also points to the reduction of general life stress and consideration
of broader life contextual factors as influential elements of diabetes management (Albright,
Parchman, & Burge, 2001; Fisher, et al., 2009). It is important to remember that 95% of diabetes
care is done by the individual themselves (Funnell & Anderson, 2000). Given the small
percentage of time interacting directly with health care providers, it is important to ensure that
educational opportunities meet the needs of the individual and support behavioural change, as
well as, knowledge transfer. When designing healthcare education or directly providing patientfocused education, health care providers need to be sensitive to individual differences in how
patients appraise, explain, and cope with stressors which are likely to influence a patient’s ability
to comprehend and retain new knowledge (Roesch, Weiner, & Vaughn, 2002).
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3.1.3 Coping and Diabetes
The need to behaviourally regulate metabolic processes that are normally controlled by
autonomic physiologic functioning makes coping with diabetes different from other chronic
illness (Karlsen & Bru, 2002). People living with diabetes must control the timing, quality and
quantity of their nutritional intake and optimize their activity and exercise levels to achieve the
targets set for optimal metabolic glycemic control. Coping with diabetes is a lifelong necessity
and impacts on the health outcomes achieved by self-management. Gafvels and Wandell (2006)
assessed coping strategies in adults with type 2 diabetes and found a clear association between
coping and metabolic control. Research examining psychosocial factors predictive of
relationships with self-care behaviour found coping efficacy uniquely accounted for 9% of the
variance in self-care behaviour (Hart & Grindel, 2010). Bandura notes that a person’s beliefs in
personal self-efficacy or coping can affect life choices, vulnerability to stress and their quality of
life functioning (1994). For health care providers caring for patients with diabetes it is essential
to have an understanding of the patient’s perception of their stress and their ways of coping with
it. Rubin and Peyrot (1999) suggested that with training, effective coping skills for diabetes selfmanagement can be developed and enhanced.

3.1.4 Education Strategies
The use of interprofessional team-based diabetes care, which includes diabetes nurse educators,
is well documented in the literature and promoted as the standard of care (Bodenheimer, Wagner,
& Grumbach, 2002; Grimmer-Somers, Dolejs, Atkinson, & Worley, 2008; Phelps et al., 2009;
Ritholz et al., 2011; Zwar et al., 2007). This type of care has also been shown to improve
glycemic control (Earles et al., 2001; Polonsky, 2003). Effective diabetes education is therefore
a key element of living well with diabetes. The Canadian Diabetes Association (CDA) defines
diabetes self-management education as “a systematic intervention that involves active patient
participation in the self-monitoring (physiological processes) and/or decision making
(managing)” (Jones, et al., 2013, p. 26). The majority of diabetes management (~80%) occurs in
the primary care setting which may influence the resources available to provide diabetes
education (Borgermans et al., 2009). In order for patients to fully participate in their educational
opportunities, assessment of their stress levels and coping processes provides educators with
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understandings to meet the individual needs of patients. It has also been shown that behavioural
interventions enhance education knowledge achieving longer term change in self-care behaviour
(M. J. Davies et al., 2008; Kulzer, Hermanns, Reinhecker, & Haak, 2007; Minet, Moller, Vach,
Wagner, & Henriksen, 2010).

3.2 Registered Nurses Association of Ontario Best Practice
Guidelines (RNAO BPG)
The RNAO BPG development is a rigorous process which includes a systematic literature review
and expert clinician and stakeholder consultation to provide evidenced-based recommendations
in four areas consisting of (a) practice, (b) education, (c) organization and policy, and (d)
evaluation and monitoring. The RNAO BPG for the Subcutaneous Administration of Insulin in
Adults with Type 2 Diabetes provides nine specific recommendations that focus on the essential
knowledge that a person requires to safely self-administer insulin (Appendix B). The RNAO
BPG is designed to assist nurses and allied health professionals who are not specialists in
diabetes care to assist clients to safely initiate and administer insulin (Registered Nurses
Association of Ontario, 2009).

3.3 Research Purpose
The purpose of this research was to examine the relationships between perceived stress and ways
of coping in patients with type 2 diabetes who initiated insulin therapy and received education
guided by the Registered Nurses Association of Ontario (RNAO) Best Practice Guideline (BPG)
for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes. The two
research questions were:

1. What is the relationship between perceived stress and education guided by the RNAO
BPG for Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes?
2. What is the relationship between perceived stress, ways of coping and the initiation of
insulin therapy in adults with Type 2 diabetes?
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3.4 Theory to Frame this Study
Lazarus and Folkman (1984) presented the cognitive theory of stress and coping, a framework
for examining psychological stress. The theory holds that stress is contextual, an interaction
between the person and his/her environment. Folkman (1997) further revised the model to
include positive psychological states. Stress, as defined by Lazarus and Folkman and the
definition used for this study, is “a relationship between the person and the environment that is
appraised by the person as taxing or exceeding his or her resources and endangering his or her
well-being” (1984, p. 21). Two concepts are central to the theory (a) appraisal and (b) coping.
Both appraisal and coping are influenced by an individual’s personal characteristics and the
environment and are therefore considered to have stable and variable aspects. Appraisal relates
to a person’s “evaluation of the personal significance of a given event and the adequacy of the
individual’s resources for coping” (Folkman & Greer, 2000, p. 12). Coping is described as a
dynamic system which is highly interactive (Folkman, 2010). Coping refers to the thoughts and
behaviors used by an individual and is subdivided into three types (a) emotion-focused coping
centered on regulating distress, (b) problem-based coping centered on managing the problem
causing distress and (c) meaning-based coping centered on the ability to maintain positive wellbeing. In this study, coping was proposed as a mediator of perceived stress and the patient’s
self-efficacy with the initiation of insulin. Lazarus and Folkman suggest that coping is a
mediator that changes the relationship between the antecedent variable (perceived stress) and the
outcome variable (insulin self-efficacy) transforming the original appraisal and attendant
emotion. According to Lazarus, “coping and the appraisals that influence it mediate any
emotions that are generated by the emotions process” (2006, p. 10).
Based on the theoretical model and examination of the literature, the following hypotheses for
this study were developed (Figure 3):
(1) Effective provision of RNAO BPG for the Subcutaneous Administration of Insulin in Adults
with Type 2 Diabetes will assist with decreasing patients’ perceived stress.
(2) Patients with higher levels of perceived stress will have lower confidence in administering
insulin and managing diet (insulin initiation self-efficacy).
(3) Patients with higher perceived stress will engage more frequently in ways of coping.

38
(4) Patients with effective ways of coping will have higher confidence in administering insulin
and managing diet (insulin initiation self-efficacy).
(5) Coping (ways of coping) is a mediating variable of the perceived stress and initiation of
insulin relationship.

3.5 Methods
3.5.1 Design and Sample
A one-group, non-experimental pretest / posttest design was undertaken drawing a sample from
patients who were seen at a Diabetes Education Centre (DEC) in Southwestern Ontario. Ethics
approval was obtained from the Western University Health Science Research Ethics Board and
the hospital ethics boards for each of the involved DECs. Participants were surveyed
immediately prior to their first visit at a DEC for education prior to starting insulin and once
again at their follow-up appointment approximately six weeks later. Appointments in the DEC
to start insulin were booked as one to one appointments with a nurse or dietitian and ranged from
45 to 90 minutes. Each participant completed the three survey tools prior to initiating insulin
therapy and the same three tools at their follow-up appointment. Additionally, a Best Practice
Guideline evaluation tool developed for this study was administered during a brief interview
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following the second appointment to evaluate the participants’ perceptions of the educational
content reviewed during their appointments. In order to be eligible for the study, participants
needed to read and speak English, be over 18 years of age and be insulin naïve with no previous
injection therapy experience with any type of injectable treatment.
The final sample was obtained from three independent DECs (n =105). After initially recruiting
113 participants, 4 participants did not return for their second visit and 4 participants were no
longer using insulin at their second appointment. The final study sample (Table 3) consisted of
58 men and 47 women with a mean age of 62 years (range 25 – 86 years). The majority of
participants were married (68%). The average duration of disease with diabetes ranged from
newly diagnosed to 36 years with a mean of 11.6 years. The majority of participants (80%) were
started on once daily (basal) injections with the remainder on Multiple Daily Injections (MDI).
Seventy per cent of participants had completed high school (42%) or college (28%).
Table 3. Demographics of final sample (n = 105)

Demographic

Frequency

%

Female

47

45

Male

58

55

Single

6

6

Married

71

68

Divorced/Separated

21

20

Widowed

7

7

Elementary School

11

11

High School

44

42

College

30

28

University

19

18

84

80

Sex

Marital Status

Education

Insulin Regimen
Basal (Once daily)

40
Multiple Daily Injections

Age (yrs)
Duration with Diabetes (yrs)

21

20

range

mean

SD

25-86

62

10.73

0-36

11.6

7.74

3.5.2 Measures
Demographic data collected to describe the study sample included sex, age, duration of diabetes,
education level completed, marital status, and type of insulin program initiated.
The Perceived Stress Scale (PSS) was used to measure participants’ stress levels (Cohen, et al.,
1983). The 10 item PSS is a self-report global stress measure using a 5 point Likert scale
ranging from 0 (never) to 4 (Very Often). The total perceived stress score is calculated by
summing all 10 items of the scale (items 4, 5, 7, 8 are reversed scored) with a possible range of 0
to 40. Higher scores reflect higher levels of perceived stress. The reported reliabilities of the
PSS demonstrate Cronbach’s alpha ranges from 0.75 to 0.91 (Reis, Hino, & Rodrigues-Anez,
2010). The Cronbach’s alpha reliabilities in this study were 0.83 (pre) and 0.82 (post).
The Ways of Coping Questionnaire (WAYS) was used in this study to measure the theoretically
derived coping relationship between stress and the participant’s self-efficacy with insulin
therapy. It was designed to identify coping processes – thoughts and actions that an individual
uses to cope with a specific stressful encounter (Folkman & Lazarus, 1988). The WAYS is a 66
item self-report questionnaire with 8 subscales measuring coping processes The 8 coping
subscales include (a) Confrontive Coping, (b) Distancing, (c) Self-Controlling, (d) Seeking
Social Support, (e) Accepting Responsibility, (f) Escape-Avoidance, (g) Planful Problem
Solving, and (h) Positive Reappraisal. Items from the 4 point Likert scale were summed, the
higher the score the greater use of a particular coping process. The Cronbach’s alpha reported
for the 8 subscales range from 0.61 to 0.79. In this study, the Cronbach’s alphas were consistent
with previously reported values for each scale with a range of 0.59 to 0.82 (pre) and 0.67 to 0.77
(post). Raw scoring was used in the final analysis, summing the scores from each of the
subscales which provided a total score. The total coping score reflected the extent to which each
type of coping was used in each encounter.
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The Confidence in Administering Insulin and Managing Diet Scale (CAI-MDS) was developed
by the Nursing Best Practice Research Unit in partnership with the Registered Nurses
Association of Ontario (RNAO) to evaluate patient outcomes with the use of the RNAO Best
Practice Guideline on Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes
(Registered Nurses Association of Ontario, 2009). It is a measure of self-efficacy and contains
21 self-report items with 2 subscales: a 12 item insulin administration scale and 9 item managing
diet scale. Cronbach’s alpha for the insulin administration scale is reported as 0.90 and 0.94 for
the diet scale. This study resulted in Cronbach’s alpha 0.70 pre and 0.86 post for the insulin
administration scale and 0.93 pre and 0.92 post for the diet scale.

3.5.3 Data Analysis
Descriptive and inferential analyses were performed using the IBM SPSS Statistics v. 22 (IBM.,
2013). Missing data accounted for less than 5% of the study data acquired therefore imputation
was not undertaken (Tabachnick & Fidell, 2001). Bootstrapping for the regression mediation
analysis was performed using the PROCESS Macro developed by Hayes (2013).
Paired-samples t-tests were performed to evaluate the impact of BPG education on participants’
scores with the variables perceived stress, ways of coping, and insulin self-efficacy from pretest
to posttest. Correlation analyses were run between perceived stress and insulin initiation selfefficacy, perceived stress and coping, and coping and insulin initiation self-efficacy to examine
the theoretical relationships hypothesized in the study model.
Mediated regression analysis was undertaken using a bootstrapping analysis to examine the
relationship between perceived stress and insulin initiation self-efficacy with coping as a
mediator. Bootstrapping is a more recent approach to testing mediation hypotheses which has
been shown to be superior to earlier methods with regard to power and Type 1 error rates
(MacKinnon, Lockwood, & Williams, 2004; Preacher & Hayes, 2008).3.6 Results

3.6.1 Research Question #1
What is the relationship between perceived stress and education guided by the RNAO BPG for
Subcutaneous Administration of Insulin in Adult Patients with Type 2 Diabetes?
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There were statistically significant differences at the p < .001 significance level, in pretest to
posttest scores for perceived stress and CAI-MDS (insulin self-efficacy) (Table 4). Results
showed that patient stress decreased and insulin self-efficacy increased after receiving the BPG
insulin education.
Table 4
Descriptive Statistics and t-test Results for Perceived Stress, Coping, and CAI-MDS (selfefficacy)
Pretest
Outcome

Posttest

95%Cl for Mean

M

SD

M

SD

n

Difference

r

t

df

Perceived Stress

16.61

7.27

14.23

7.02

97

1.07, 3.71

.58*

3.60*

96

Coping

76.38

31.07

73.51

31.22

97

-2.00, 7.756

.70

1.17

96

CAI-MDS
(self-efficacy)

76.71

14.23

86.93

10.85

98

-12.90, -7.52

.45*

-7.54*

97

*p < .001

3.6.2 Research Question #2
What is the relationship between perceived stress, ways of coping and the initiation of insulin
therapy in adults with type 2 diabetes?
The correlation analyses indicated perceived stress had a moderately positive correlation with
coping and a weak, inverse correlation with insulin initiation self-efficacy. There was a nonsignificant relationship between coping and insulin initiation self-efficacy (See Table 5).

Table 5
Bivariate Correlations Among Perceived Stress, Coping, and CAI-MDS (self-efficacy)
Variable

1

1 Perceived Stress
2 Coping
3 CAI-MDS (self-efficacy)
*p < .05

** p < .01

-

2

3

.39**

-.21*

-

.10
-
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The paired t-test scores of pretest and posttest for coping suggested fewer coping processes were
employed posttest, however, this result was not statistically significant (Table 4).

Table 6 presents the bivariate correlations between perceived stress, the 8 subscales of coping
and the 2 subscales of the CAI-MDS (insulin initiation self-efficacy). The 8 coping subscales
include (a) Confrontive Coping, (b) Distancing, (c) Self-Controlling, (d) Seeking Social Support,
(e) Accepting Responsibility, (f) Escape-Avoidance, (g) Planful Problem Solving, and (h)
Positive Reappraisal. The 2 subscales of the CAI-MDS are (a) insulin self-efficacy and (b) diet
self-efficacy.
Table 6
Posttest Bivariate Correlations Among Perceived Stress, Coping (subscales), and CAI-MDS
(insulin initiation self-efficacy subscales)
Variable
1 Perceived
Stress
2 Confrontive
Coping
3 Distancing
4 SelfControlling
5 Seeking
Social Support
6 Accepting
Responsibility
7 EscapeAvoidance
8 Planful
Problem
Solving
9 Positive
Reappraisal
10 Insulin
Self-Efficacy
11 Diet
Self-Efficacy
*p = < .05

1
-

2
.22*

3
.25*

4
.34*

5
.17

6
.37*

7
.44*

8
.16

9
.09

10
-.17

11
-.19

-

.34*

.60*

.46*

.46*

.35*

.54*

.33*

-.01

.03

-

.55*

.37*

.59*

.38*

.37*

.40*

.13

.05

-

.40*

.61*

.47*

.57*

.41*

.10

-.01

-

.31*

.26*

.50*

.47*

.07

.17

-

.53*

.39*

.44*

.03

-.01

-

.03

.19*

-.11

-.17

-

.49*

.22

.22*

-

.01

.08

-

.55*
-
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The mediated regression analysis examined the relationship between perceived stress and CAIMDS (insulin initiation self-efficacy) with coping as a mediator. Regression analyses
demonstrated statistically significant relationships between perceived stress and insulin initiation
self-efficacy (β = -0.208, p < .05), perceived stress and coping (β = 0.390, p = < .001) and
perceived stress and coping predicting insulin initiation self-efficacy (see Figure 4). A biascorrected bootstrap 95% estimate of the confidence interval for the indirect effect of coping
(.153) based on 5000 bootstrap samples was entirely above zero (0.023 to 0.281). Since the
confidence interval did not include zero, the indirect effect of coping was shown to be a mediator
of the relationship between perceived stress and insulin initiation self-efficacy.

3.6.3 Hypotheses Results
(1)

Effective provision of the RNAO BPG for the Subcutaneous Administration of Insulin in

Adults with Type 2 Diabetes will assist with decreasing patients’ perceived stress.
Pretest to posttest scores for perceived stress demonstrated a statistically significant decrease
therefore this hypothesis was supported.
(2)

Patients with higher levels of perceived stress will have lower confidence in

administering insulin and managing diet (insulin initiation self-efficacy).
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The study findings of an inverse, although weak correlation between perceived stress and CAIMDS (insulin self-efficacy) supported this hypothesis.
(3)

Patients with higher perceived stress will engage more frequently in ways of coping.

There was a moderately positive correlation between perceived stress and coping which
supported this hypothesis.
(4)

Patients with effective ways of coping will have higher confidence in administering

insulin and managing diet (insulin initiation self-efficacy).
The correlation between coping and insulin self-efficacy was non-significant therefore this
hypothesis was not supported.
(5)

Coping (ways of coping) is a mediating variable of the perceived stress and initiation of

insulin relationship.
The results of the mediated regression analysis supported this hypothesis.

3.7 Discussion
The first study aim was to examine the relationship between perceived stress and the influence of
education guided by the RNAO BPG for the administration of insulin in adults with type 2
diabetes. The findings supported the hypothesis that there would be a significant decrease in
participants’ stress scores following their two appointments for insulin initiation education at the
diabetes education centre (DEC). Perceived stress was inversely related to a participant’s insulin
initiation self-efficacy i.e. as stress decreased the participant’s insulin self-efficacy increased.
The improvement in insulin initiation self-efficacy scores was also significant. Researchers have
suggested that determining a patient’s overall general stress response, as done in this study, may
be more beneficial in determining strategies to assist with self-management versus focusing on
diabetes distress (Albright, et al., 2001). These findings highlight the need to assess patients
individually to determine how stress may impact their learning ability and affect their ability to
acquire the skills needed to self-administer insulin effectively.
The second aim of this study was to examine the relationships between perceived stress, ways of
coping, and insulin initiation self-efficacy and determine whether coping mediated the
relationship between perceived stress and insulin initiation self-efficacy. Findings supported that
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perceived stress and coping were significant predictors of insulin initiation self-efficacy which is
consistent with the Lazarus and Folkman theoretical framework in this study. Coping was
shown to be a mediator of the relationship between stress and insulin initiation self-efficacy. This
is consistent with the findings of Lazarus and Folkman who have emphasized that coping
mediates any emotions that may be generated during the emotions process (2006). Research in
diabetes care has suggested that with training, effective coping skills can be developed and
enhanced (Rubin & Peyrot, 1999). Hart and Grindel suggested that coping uniquely accounted
for a 9% significant variance in self-care behaviour with higher self-care behaviour resulting in
better controlled diabetes (2010). This is an important element of diabetes self-management
education as patients need to build a strong foundation of knowledge and skills to carry them
over the lifetime of their chronic disease management. Diabetes nurse educators and allied
health providers are well positioned to assist patients in the development of coping processes that
will result in improved self-care behaviour.

3.7.1 Practical Implications
Research supports the use of a team approach which includes nurse and dietitian diabetes
educators. Not all patients will have access to a diabetes education centre as was the situation in
this study. With the majority of diabetes management occurring in primary care settings, the
integration of a diabetes educator into the primary care team could help to improve patients’
ability to self-manage. The results of this study suggest assessment of stress and coping would
be beneficial for patients initiating insulin therapy. An awareness of the patient’s stress level and
coping processes can help tailor the education provided to meet the individual’s needs. The use
of a short stress survey such as the Perceived Stress Scale can easily and quickly be administered
prior to an appointment or education session and can provide useful insight into the patient’s
stress level. It can also serve to encourage patient self-reflection and dialogue between the
patient and educator which allows for exploration of patient questions or concerns. The RNAO
BPG is an evidence-based guideline that can be applied by healthcare providers with or without
speciality knowledge in diabetes. The findings suggest that the use of a best practice guideline
can help patients to become self-efficacious with insulin therapy and also help to decrease their
stress levels.
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3.7.2 Limitations
Convenience sampling limits the generalizability of this study. The use of a control group that
did not receive BPG education would have provided a more robust design. The standard of care
for diabetes education centres, however, is to provide at least one appointment providing basic
education with regard to insulin injection, home glucose monitoring, and potential safety
concerns such as hypoglycemia. All of the questionnaires used were self-report which may have
influenced participant responses. Patients with diabetes often report self-blame (Karlsen, et al.,
2012). If participants struggled with their diabetes self-management, they may have felt the need
to provide desirable survey responses.

3.8 Conclusion
The incidence of type 2 diabetes continues to increase exponentially throughout the world
(International Diabetes Federation, 2013) and there is strong research evidence for the benefits of
glycemic control to minimize the complications of diabetes and improve quality of life (United
Kingdom Prospective Diabetes Strategy (UKPDS) Group, 1998). Clinical practice continues to
evolve with a move to reduce clinical inertia amongst health care providers regarding the use of
insulin therapy. Increasing numbers of patients with diabetes will require insulin therapy to
achieve target glycemic control. The holistic approach of nursing lends itself to meeting both the
psychological (stress and coping) and physiological (insulin initiation self-efficacy) needs of
patients living with diabetes. This study provided evidence that the needs of these patients can
be met with structured education through the use of a Best Practice Guideline. Strategies to
decrease patient stress and improve coping may help to improve patient self-efficacy with insulin
therapy.
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Chapter 4
4

Evaluating the Use of a Best Practice Guideline with Insulin
Initiation in Type 2 Diabetes

4.1 Introduction
Providing patient-focused quality care is one of the quintessential tenets of the nursing
profession. Nursing practice continues to advance as our knowledge of health and health care
provision incorporates new research and enhanced understandings of the needs of those we care
for. The movement to evidence-based care gained momentum in the 1990s as clinicians
articulated the need for the integration of clinician expertise in combination with systematic
clinical research evidence (Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996). Best
practice guidelines (BPGs) are now used in clinical practice to provide healthcare professionals
with a synthesis of the research and expert knowledge related to a specific issue or concept.
Nelson (2014) examined the concept of best practice in nursing and its increasing presence in the
literature noting that the evaluation of best practice guidelines is an area that requires further
development. Evaluating best practice guidelines allows healthcare providers to determine the
feasibility of implementing the BPG, its potential to influence patient satisfaction, and whether it
is cost-effective (Mezey, Fulmer, Abraham, & Zwicker, 2003). In this paper the results are
presented of research examining the use of a BPG evaluation tool (Appendix B) with education
guided by the RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2
Diabetes (Registered Nurses Association of Ontario, 2009).

4.2 Background
The use of evidence-based clinical practice guidelines provides clinicians with tools and
resources to assist patients to optimize their health. In 1999, the Registered Nurses Association
of Ontario (RNAO) in collaboration with the Ontario Ministry of Health and Long Term Care
began a Best Practice Guideline (BPG) development program. To date over 50 BPGs have been
developed encompassing a wide variety of clinical subject areas such as diabetes, pain
management, and facilitating client-centred learning (Registered Nurses Association of Ontario,
2015). The development of an RNAO BPG is a rigorous process which includes topic selection
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by key stakeholders, critical appraisal of the literature by an expert panel, data extraction and
draft of BPG recommendations, review of the draft by external stakeholders with subsequent
revision of the BPG, and finalization of the BPG and related educational, implementation, and
evaluation tools (Virani & Grinspun, 2007). Guidelines are to be reviewed and updated every 3
years or more frequently as necessary. (However, the BPG involved with this study has not been
revised since 2009). The final versions of the RNAO BPGs provide recommendations in 4 main
areas: clinical practice, aimed at nursing; educational, directed at practice competencies;
organizational/policy, directed at the organizational environment to facilitate practice and
evaluation/monitoring indicators of the BPG (Registered Nurses Association of Ontario, 2009).
Clinical recommendations can be used by nurses and collaboratively with allied health providers
to enhance direct patient care.
Numerous organizations such as the AGREE Collaboration, Guidelines International Network,
and RNAO champion the evaluation of clinical practice / best practice guidelines (Makarski &
Brouwers, 2014; Network., 2002; Registered Nurses Association of Ontario, 2015). The
AGREE collaboration, a group of international guideline developers and researchers, developed
the AGREE II instrument, to provide a framework to assess clinical practice guideline (CPG)
quality (Brouwers et al., 2010). The authors noted that CPGs are relied upon by clinicians to
make patient care decisions and can also play an important role in health policy formation and
thus must be of high quality to ensure best possible patient care. Uptake of the AGREE
instruments has been extensive with translation of the instruments into 33 languages and over
600 article citations which emphasizes the value ascribed to guideline evaluation. Nurse
researchers also recognize the critical role guideline evaluation plays and encourage healthcare
professionals to carefully consider guideline evaluation in addition to guideline adoption
(Graham & Harrison, 2005) .
Type 2 diabetes affects 90% of those people living with diabetes (Centre for Disease Control and
Prevention, 2014; Government of Canada, 2013).

The challenge for people living with diabetes

is to achieve glycemic targets that will help to decrease the probability of developing the
devastating complications of the disease. People living with diabetes have a mortality rate of at
least twice as high as those without diabetes (Public Health Agency of Canada, 2011a).
Macrovascular complications such as heart attack and stroke and microvascular complications
such as retinopathy, nephropathy, and neuropathy can be minimized or avoided with optimal
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blood sugar control (Brownrigg et al., 2014; Holman, et al., 2008; Reyden et al., 2013; United
Kingdom Prospective Diabetes Strategy (UKPDS) Group, 1998) . Many people, however, have
difficulty achieving the recommended glycemic targets. Only 50% of Canadians living with
diabetes are reported to have achieved the recommended glycemic targets (Leiter, et al., 2013a).
The reasons for this are multifactorial and include psychological aspects, socioeconomic
influences, access to care and education, and the progressive nature of diabetes (Canadian
Diabetes Association, 2013a).
A challenge for professionals providing diabetes care is to provide patient-focused education
within the constraints of a healthcare system that often limits the time available to interact with
patients. The psychological aspects of diabetes are well documented and include the phenomena
of diabetes distress and psychological insulin resistance. Diabetes distress, disease specific stress
related to the burden self-care management of diabetes is established in the literature, as well as
the challenges associated with its identification and treatment (Fisher, et al., 2009; Paddison, et
al., 2007; Peyrot, et al., 2005; Peyrot, et al., 2006). Psychological insulin resistance is defined as
a psychological barrier or opposition to initiation of insulin (Brod, et al., 2009; Gherman, et al.,
2011; Polonsky, 2007) and is present in both clinicians and patients. A related concept, clinical
inertia is the term used to describe reluctance by healthcare providers to initiate new treatments
such as insulin therapy (Brown, et al., 2004; Harris, et al., 2010b; Harris, et al., 2008; Phillips, et
al., 2001). Reluctance to initiate insulin often results in prolongation of hyperglycemia which
unnecessarily increases the risk of diabetes complications and mortality. Additionally, 95% of
diabetes care is self-managed emphasizing the importance of effective, efficient educational
interactions (Funnell & Anderson, 2000). The RNAO BPG for the Subcutaneous Administration
of Insulin in Adults with Type 2 Diabetes provides an evidence-based, structured resource for
nurses caring for patients needing to initiate insulin therapy. This study examines participants’
recall of the content of the RNAO BPG for the Subcutaneous Administration of Insulin in Adults
with Type 2 Diabetes using a BPG evaluation tool developed for this study. This study was
derived from a quantitative study examining stress, ways of coping, and insulin initiation selfefficacy (Loft, Forchuk, Kerr, & Harris, 2015).
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4.3 Research Purpose
The purpose of this research was to examine participant recall of diabetes education based on the
RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes
when initiating insulin therapy and to examine a BPG evaluation tool developed for this study
for use specifically with this RNAO BPG.
The research questions were:
1. “What is the level of participant recall of diabetes education using the RNAO BPG for the
Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes as evaluated by a novel
BPG evaluation tool?”
2. “What is the patient experience of initiating insulin therapy when receiving structured Best
Practice Guideline diabetes education?”
The terms recall and retention have similar meanings, however, for this study the term recall was
chosen. The term “participant recall” describes more closely the elements of the BPG education
that participants remembered. The challenge with using the term retention was the implication
that all of the elements of the BPG had been presented by the educators to the participants which
might not have occurred.

4.4 Methods
4.4.1 Design and Sample
A pretest / posttest, non-experimental, mixed-methods design utilized one group of participants.
A convenience sample was drawn from patients attending one of three independent Diabetes
Education Centres in Southwestern Ontario for the initiation of insulin therapy. Participants
were adults over the age of 18 with no prior history of injection or insulin therapy. Ethics
approval was obtained from the Western University Health Science Research Ethics Board.
Participants were interviewed following two appointments to receive insulin therapy education
with the first appointment providing the education to initiate insulin therapy. The second
appointment was a follow-up approximately six weeks after the initiation of insulin. During one
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to one education sessions, diabetes educators (registered nurses or registered dietitians) provided
education which focused on the clinical recommendations of the RNAO BPG. Education
sessions ranged from 45 to 90 minutes. Participants were interviewed by a member of the
research team in person or by telephone following their six week appointment to complete the
RNAO BPG evaluation tool. Three open ended questions were also included during the
interview: 1. “Please describe how you felt when you were asked to start using insulin”, 2.
“What was the most challenging thing about starting insulin?”, 3.”What made it easier to start
using insulin?”. Ethics approval was obtained from the Western University Health Science
Research Ethics Board and for each Diabetes Education Centre involved in the research.

4.4.2 Instruments
A Best Practice Guideline evaluation tool was developed for this study to be used with the
RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes
(Registered Nurses Association of Ontario, 2009). Designed to be used during a face to face or
telephone interview, it was developed to be consistent with chart audit tools previously
developed by the Nursing Best Practice Research Unit (NBPRU) (Edwards et al., 2003). Prior to
use in this study, the tool was reviewed and revised by clinical experts working in diabetes.
Experts familiar with RNAO BPG development and implementation also reviewed the novel
evaluation tool. No changes were recommended by the clinical or BPG experts with respect to
the content of the evaluation tool. Revisions were made to ensure clarity of the questions and to
ensure each question evaluated a single concept. The tool evaluates participant recall of clinical
practice recommendations from the RNAO BPG for the Subcutaneous Administration of Insulin
Adults with Type 2 Diabetes, for example, “Did the educator assess stressors about insulin
initiation with the patient? Was the patient asked to set a goal for the education session?”. There
are 22 items with a yes or no response with yes = 1 point, no = 0 points. Scores can range from 0
to 22. Higher scores reflect higher recall of this study’s RNAO BPG content by the participant.

4.4.3 Analysis
Descriptive statistics and the reliability score of the BPG evaluation tool were obtained using the
IBM SPSS Statistics v. 22 (IBM., 2013). The level of participant recall of the content of the
BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes was
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evaluated by determining participants’ total score obtained with the evaluation tool developed for
this study.
Qualitative data from the open-ended questions included on the BPG evaluation tool were
transcribed verbatim during the interview. Using the approach described by Hsieh and Shannon
(2005) a conventional content analysis approach was undertaken. Content analysis offers a
flexible approach to extend knowledge of the human health experience. Participant responses
were analyzed and coded to enable a deductive analysis and determine categories of participant
responses. Exemplars from each category were selected to provide further insight into
participant experience with insulin initiation and BPG education.

4.5 Results
A final sample size of n = 105 was obtained from participants who completed the two DEC
appointments and the BPG evaluation interview. (Table 1)
Demographics
Table 1: Demographics of final sample (n = 105) (Loft, et al., 2015)
Demographic

Frequency

%

Female

47

45

Male

58

55

Single

6

6

Married

71

68

Divorced/Separated

21

20

Widowed

7

7

Elementary School

11

11

High School

44

42

Sex

Marital Status

Education

59
College

30

28

University

19

18

Basal (Once daily)

84

80

Multiple Daily Injections

21

20

Insulin Regimen

Age (yrs)
Duration with Diabetes (yrs)

range

mean

SD

25-86

62

10.73

0-36

11.6

7.74

4.5.1 BPG Evaluation Tool
The Cronbach’s alpha an estimate of the internal consistency for the BPG evaluation tool was
calculated to be 0.57. Removing the first item of the tool, “Did the educator ask you about your
beliefs about insulin therapy?” increased the Cronbach’s alpha to 0.70 which is considered an
acceptable internal consistency. Final analysis was therefore done with the first item removed
from the original BPG evaluation tool leaving a total of 21 items in the final scale.
The mean score on the Best Practice Evaluation tool to assess participant recall of the BPG
content was 16.7 (SD = 2.19) resulting from a possible maximum score of 21.

The frequency

scores of patient recollection of the BPG content reviewed during their appointments are
summarized in Table 6.
Table 6
Best Practice Guideline response frequency
BPG Question Summary

Frequency

%

(N = 105)

(yes)

(yes)

27

26

105

100

Did your educator ……
ask you to set a goal for your education session?
provide basic nutrition information?

60
Insulin preparation and administration
review your type of insulin?

103

98

review the action of your insulin?

101

96

review the stability of your insulin?

101

96

review the storage of your insulin?

102

97

99

94

review injection technique?

100

100

review sharps disposal?

100

100

review the frequency of blood glucose testing?

104

99

review the recommended targets for blood glucose?

104

100

83

79

104

99

review how to prevent hypoglycemia?

101

96

review how to recognize hypoglycemia?

102

97

review how to treat hypoglycemia?

102

97

94

90

review blood glucose monitoring during periods of illness?

57

54

ask you when you should seek healthcare assistance?

62

59

review use of easily digested carbohydrates?

30

29

review how to prevent dehydration?

27

26

review the compatibility of your insulin?

Self-monitoring of blood glucose (SMBG)

review how to verify meter accuracy?
review SMBG technique?
Hypoglycemia education

ask if family members were aware of hypoglycemia treatment?
Sick Day Management

The majority of BPG items were recalled by greater than 90% of the participants. Items related
to sick day management, meter accuracy, and patient goal setting were recalled at noticeably
lower rates (26-59%).
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4.5.2 Participant Interviews
Participants’ responses to the open ended questions asked following their second appointment
were analyzed. Three distinct categories emerged: 1. Psychological Insulin Resistance, 2.
Insulin Therapy Preconceptions, and 3. Educational Impact. Interview lengths ranged between 6
and 16 minutes which included the completion of the BPG Evaluation Tool. In total, 98
participants provided responses to the open-ended questions with 7 participants preferring not to
respond.

4.5.3 Psychological Insulin Resistance (PIR)
The majority of patients described some element of PIR - the psychological barrier or opposition
to initiation of insulin (Brod, et al., 2009; Gherman, et al., 2011; Polonsky, et al., 2011).
Participant responses were consistent with previous research which identified emotional
elements such as anxiety, depression, fear of needles or injection pain, and the belief that
diabetes is worsening as barriers to insulin initiation (Gherman, et al., 2011).
Describing his reaction to the need to initiate insulin therapy, a 72 year old male who had been
living with diabetes for 14 years responded,
“Another step down into the basement. I felt like it was the end of the road. I'm gonna be dead.
Sticking a needle into me was the worst fear. But now I realize that I should have gone on insulin
years ago. I just didn't think I could do the needle.”
Similarly, a 49 year old male with a 2 year history of diabetes commented,
“I saw it as a "no turning back" kind of thing. Insulin seemed like a death nail, it's for life. This
stuff messes with your head. It's like you're going down a path of unhealthiness. Now, injecting
the insulin is not a big deal.”

4.5.4 Insulin Therapy Preconceptions
Many patients appeared to have a lack of knowledge related to the current methodologies for
insulin therapy. Their understanding of insulin therapy was often based on the experience of
others who had started insulin therapy prior to the newer modalities now available.
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Misconceptions regarding insulin therapy have been identified in the literature with some
patients attributing such things as heart attack, amputation, and blindness as resulting from the
use of insulin (Karter et al., 2010).
“It wasn't good. I didn't know about all the new needles. My sister had diabetes and she had long
needles and she had to boil them. It was so much work.” (62 year old female with 1 month
history of diabetes)
“I was very nervous and unsure about it. The impact is pretty good that it (insulin) is working. I
wondered about the needle and how painful it would be. It's kind of mind over matter. It's not
anywhere near as bad as when my father was a diabetic - that was why I thought it was so
terrible. He had to boil his needles and everything. But once you see that it's just a pen, it's really
quite easy.” (66 year old male with 14 year history of diabetes).

4.5.5 Educational Impact
The impact of RNAO BPG education could be seen in comments that expressed a negative
response to the need to begin insulin therapy but suggested a positive opinion of the education
that was received.
“No way! I hated needles. I've gotten enough control over it now. I realize that I have to be on
the insulin. I've been avoiding it for years. I just hated the thoughts of being diabetic and being
on insulin made it real that I was a diabetic. The education has helped. I know it's ok to be
diabetic.” (56 year old male with 5 year history of diabetes)
“I didn't really want to. At first he kept saying lose some weight but I just couldn't. It came down
to the point where he said ‘You better be on insulin’ now I know it's so easy. The needles are so
small and they don't even hurt. The needles. I just didn't like the word - needles. The educators
were very knowledgeable. That's very good.”(70 year old female with 14 year history of
diabetes)
No negative comments regarding the BPG education were expressed by participants in this
study. Comments by participants did not identify any specific educational elements of the BPG
referring to the education as a more global experience. Participants appeared to value their
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interaction with the diabetes healthcare providers, and often contrasted current knowledge with
past preconceptions.
“I was diagnosed 28 years ago. My doctor took me aside and said that I would one day need
insulin. I was terrified though. I didn't sleep at all before coming in (for this appointment). I feel
a lot more secure. The educators 28 years ago put the fear of God in you. You're going to be
dead. This time it was all about them listening to me. I felt like I was heard.” (58 year old male
with 28 year history diabetes)
“Support from the diabetes education doctors and nurses. They have a very good education
program.”(44 year old male with 6 year history of diabetes)

4.6 Discussion
There was effective provision of the RNAO BPG with the average score ( 16.71 out of 21 ) from
the evaluation tool indicating that 80% of the RNAO BPG content was recalled by participants
as having been discussed during their appointments. Previous evaluations of RNAO BPG have
included the evaluation levels recommended by Kirkpatrick and Kirkpatrick (2007). Level 1Reaction, relates to the degree of participant satisfaction with the education, Level 2 – Learning,
relates to the degree to which participants gain the intended knowledge, skills, attitudes and
confidence, Level 3- Behavior – relates to the degree to which participants and staff apply what
has been learned and Level 4 – Results- relates to targeted patient outcomes. This study provided
Level 2 results reporting patient knowledge gained through the use of the RNAO BPG. In the
related intervention study by Loft et al. (2015) which examined stress and insulin initiation selfefficacy prior to and following the RNAO BPG guided education, there was a statistically
significant decrease in participants’ stress scores. Additionally, there was a statistically
significant increase in participants’ insulin therapy self-efficacy scores. Both the BPG
evaluation tool findings and participant interview responses support the positive impact of the
RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes.
The BPG evaluation tool results revealed, however, that items associated with sick day
management were not recalled as consistently as other elements of the BPG. Study design did
not allow for identification of the cause of this deficit (i.e. not communicated effectively by
educators or reduced uptake by participants). This is an important area for further research.
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Although sick day management may not occur frequently, it is essential for a patient to have the
recall knowledge to manage sick day issues when they arise. If patients are unable to self-adjust
insulin dosing or prevent dehydration, medical intervention may be required leading to
utilization of their primary care provider or potentially urgent emergency room access.
Participant inclusion in goal setting for the education sessions also demonstrated low recall with
only 26% of the participants recalling the opportunity to set a goal for their insulin initiation
education. In order to truly provide patient-centred care it is important to fully engage the
patient in shared decision-making. Patient-directed goal setting reflects one of the essential
elements of motivational interviewing (MI) which is a concept that has become one of the
preferred approaches in chronic disease management and is particularly relevant in diabetes
(Kalra, Kalra, & Batra, 2010; Levich, 2011). Motivational interviewing, as defined by Rollnick
and Miller (1995), is a directive, client-centred counseling style aimed at promoting behavior
change in clients as they resolve their ambivalence. Motivational interviewing in Type 2
diabetes has been shown to be a more effective approach for improving patient self-management
(Li, Li, Shi, & Gao, 2014), to improve depressive symptoms and time spent exercising in
American Indians (Calhoun et al., 2010), and was preferred over standard care in a qualitative
study with focus groups in family practice clinics (Dellasega, Tiangco, & Gabbay, 2012). This
finding from the BPG evaluation tool highlights a key area for improvement in patient-centred
diabetes education, reminding nurses and interprofessional team members to fully engage their
patients to increase patient engagement and success.
This was the first use of this newly developed BPG evaluation tool for this RNAO Best Practice
Guideline. Three items of the tool showed no variance and could be deleted. These related to
whether insulin injection, disposal of needles or syringes, and basic nutrition information were
reviewed during the education sessions. Further revision and evaluation of the tool would be
beneficial for future research and to compare diverse BPGs.
The participant interview qualitative responses were consistent with the current literature with
respect to psychological insulin resistance. Preconceptions and misconceptions regarding insulin
are also common in the literature, particularly in patients who are reluctant or refuse to initiate
insulin therapy (Polinski et al., 2013). Although PIR is well recognized the challenge has been
to find a mechanism to readily identify it and then work to minimize it. It is difficult to
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generalize strategies to decrease PIR as strategies need to be tailored to the unique needs of the
patient. The participant responses in this study support the findings of Polonski et al. (2013) who
suggested that once patients become familiar with insulin therapy it becomes much less of a
barrier.

4.7 Limitations
The Canadian Diabetes Association clinical practice guidelines and the RNAO BPG endorse the
need for patient education with the initiation of insulin. Given these recommendations, the study
design did not include a control group that did not receive insulin initiation education. A control
group would have offered a more robust design for this research. Convenience sampling
increases the likelihood of participant bias and decreases the generalizability of these findings.
Study design did not include an instrument to assess the provision of the BPG by the diabetes
educators. The BPG evaluation interview was not an in-depth interview which limited the depth
of the qualitative analysis possible. Participant responses to the open-ended questions on the
BPG evaluation tool were manually transcribed during the interviews which limited the quantity
of data that could be collected. The primary researcher was directly involved with the majority
of data collection. The BPG itself has not been revised since 2009 which introduces the risk that
clinical best practices have likely evolved since the BPG introduction.

4.8 Conclusion
The BPG evaluation tool developed for use with the RNAO BPG for the Subcutaneous use of
Insulin in Adults with Type 2 Diabetes was effective in this study and requires only a short time
to administer. Participants’ preconceived ideas or previous exposure to insulin therapy, through
that of a friend or relative, identified a knowledge deficit related to the current insulin therapy
modalities available today. The participant interview responses reinforce the need for early
patient education regarding the pharmacologic agents, including insulin, used to manage
diabetes. Ideally, education should begin at the time of a patient’s diabetes diagnosis with
insulin being presented as just one of the options available and not used as a threat or in a treat to
failure approach. Patients need to have a clear understanding of the relative ease with which
insulin therapy can be incorporated into an active, healthy lifestyle. Nurses, in collaboration
with the interprofessional team, need to ensure that patients do not experience unnecessary
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anxiety or stress related to an obsolete understanding of how insulin therapy is provided today.
The results from this study provided evidence that the RNAO BPG for the Subcutaneous
Administration of Insulin in Adults with Type 2 Diabetes can be an effective tool in the
provision of insulin initiation education.
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Chapter 5
5.

Discussion

This final chapter is a summary of the research findings with a discussion of implications and
recommendations for future research. The purpose of this dissertation was to examine perceived
stress and coping in adults with Type 2 diabetes who initiated insulin therapy after receiving an
education intervention guided by a Best Practice Guideline (BPG). The research questions were:
(a) What is the relationship between perceived stress and diabetes education guided by the
Registered Nurses Association of Ontario (RNAO) BPG for the Subcutaneous Administration of
Insulin in Adult with Type 2 Diabetes who initiate insulin therapy? (b) What is the relationship
between perceived stress, ways of coping and the initiation of insulin therapy in adults with Type
2 diabetes? (c) What is the level of participant recall of diabetes education using the RNAO
BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes as evaluated
by a novel BPG evaluation tool? and (d) What is the patient experience of initiating insulin
therapy when receiving structured Best Practice Guideline diabetes education?” It was
hypothesized that effective provision of the RNAO BPG would reduce patient stress and that
patients with higher levels of stress would have lower confidence with insulin therapy selfefficacy. Related to coping, it was hypothesized that patients with higher stress levels would
enact ineffective coping and that patients with effective coping would have higher confidence
with insulin therapy self-efficacy. Finally, coping was hypothesized to be a mediating variable
in the relationship between stress and insulin therapy self-efficacy.

5.1 Key Findings
5.1.1 Stress
The findings demonstrated a statistically and clinically significant decrease in patient stress after
receiving the RNAO BPG education. There was a moderate, positive correlation between stress
and coping indicating that as stress increased patients needed to enact additional coping
processes. There was an inverse correlation between stress and insulin therapy self-efficacy,
indicating stress decreased as participants became more self-efficacious with their insulin
therapy, however, the correlation was weak ( r = -.21 ).
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5.1.2 Coping
Although coping scores decreased from pretest to posttest, which would reflect a decreased need
to enact coping processes, the decrease was not statistically significant. As well, the correlation
between coping and insulin therapy self-efficacy was non-significant. Coping is a
multidimensional construct with Lazarus and Folkman identifying eight different types of coping
processes (Lazarus & Folkman, 1984). The coping processes are categorized as either problemfocused or emotion-focused coping. It is important to note that Lazarus stresses that neither type
of coping process is inherently better than the other and that the environmental context will
influence the coping processes used (Lazarus, 2006). Problem-focused processes include
positive reappraisal, planful problem solving, accepting responsibility, and seeking social
support. Emotion-focused coping strategies include distancing, self-controlling, confrontivecoping, and escape-avoidance (Lazarus & Folkman, 1984). The complexity and
multidimensionality of coping may have made it difficult to demonstrate a difference between
pretest and posttest scores.
Of interest, however, is the finding that coping did mediate the relationship between stress and
insulin therapy self-efficacy. How an individual chooses to cope in a given situation is fluid and
changes with a person’s appraisal of the situation and the environmental context. Lindley and
Noble-Walker (1993) noted that a mediator variable often represents a process that is intrinsic to
an individual . Lazarus and Folkman suggested that coping is a mediator and emphasized that
coping mediates any emotions that are generated by the emotions process (Folkman & Lazarus,
1988; Lazarus, 2006). The addition of an instrument to further assess a participant’s emotional
state would have provided data for a more thorough statistical analysis of correlations and
analysis of variance between the study variables of coping, stress, and self-efficacy.

5.1.3 Best Practice Guidelines
The BPG evaluation tool indicated the participants recalled the majority of the RNAO BPG
content that was presented to them. Asked to describe their feelings when initiating insulin
therapy, the majority of participant responses reflected the findings in the literature seen with
psychological insulin resistance such as fear, reluctance, disappointment and self-blame (Krall et
al., 2015; Peyrot, et al., 2005). It was encouraging that after receiving the RNAO BPG education
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that participant responses indicated satisfaction with the education process and that insulin selfefficacy scores also increased.
Two areas that were not recalled adequately by participants included BPG content related to sick
day management and patient-directed goal setting. Sick day management is an essential element
of diabetes self-care management. Although patients may not experience illness with a high
frequency, having the knowledge to effectively manage insulin dosing, prevent dehydration, and
knowing how to modify dietary intake could prevent the need to access higher acuity healthcare
services. Therefore it is important that patients have a strategy in place to access sick day
management information when necessary. Healthcare providers should provide patients with
resources in the form of printed materials or web-based information to access should they
become ill. Patients should also be encouraged to speak with their pharmacist about their
medications. Having patients provide a verbal confirmation to the question, “What would you
do if you were sick and couldn’t take your insulin?” will allow care providers to assess if patients
have a good understanding of what they need to do should they become ill.
The low rate of participant recall of being asked to set a goal for their education session is cause
for concern. Critical for engaging patients in their diabetes self-management is the need to
employ counseling approaches, such as motivational interviewing, which encourages patients to
self-direct their care. Motivational interviewing has been shown to be a more effective approach
for improving self-management in patients with Type 2 diabetes than traditional educational
approaches (Li, et al., 2014). To ensure patients feel engaged in the education process, putting
their education goals in writing or perhaps having them verify their goal as it is entered into their
health record can be of benefit. For healthcare providers using electronic health records, the use
of mandatory reporting fields that call for patient-driven goals to be entered can prompt
providers to ensure goal-setting is reviewed.

5.2 Implications and Future Research
The findings of this study provided clear evidence that there is more work that needs to be done
to improve the patient experience for adults with Type 2 diabetes initiating insulin therapy. The
use of a Best Practice Guideline that can assist with structured education has been shown in this
study to decrease patient stress and improve insulin initiation self-efficacy. The task now is to
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integrate the use of a BPG into primary care practice settings where the majority of diabetes
clinical management occurs. In Canada, patients with diabetes have 1.42 times as many visits to
primary care than patients without diabetes (Greiver et al., 2013). Improvements into the
provision of insulin initiation education will require changes on several levels.
At the macro level, funding for primary care must be sufficient to allow family practice settings
to have access to adequate human resources such as nurses with diabetes expertise. Adequate
clinic time must also be available to provide diabetes education, particularly for patients needing
to initiate insulin. As the prevalence of diabetes continues to grow, the numbers of patients
requiring insulin therapy will also continue to grow. The healthcare system must be able to
accommodate the needs of patients initiating insulin therapy to ensure that they feel confident to
effectively manage their insulin therapy which should lead to improved glycemic control and the
minimization of diabetes complications.
At the healthcare provider level, psychological insulin resistance (PIR) is well recognized in the
literature in the form of clinical inertia. Some clinicians do not feel confident that their patient
will be able to cope emotionally with insulin therapy or be able to acquire the skills necessary to
safely manage insulin therapy. Others cite lack of time and resources to teach insulin therapy.
Despite educational efforts to assist healthcare providers to confidently prescribe and initiate
insulin, it is evident that some reluctance remains (Krall, et al., 2015). Unfortunately, the
paradigm of using patients’ fear of insulin as a leveraging agent to target weight loss and dietary
compliance also continues to be an issue. As clinicians become more confident with initiating
insulin therapy and motivational interviewing becomes a standard approach for patient
counselling, it is hopeful that using the “threat” of insulin will no longer be an issue.
It is possible that the elevated stress level that participants experienced prior to initiating insulin
therapy included some element of self-blame or feelings of failure when insulin became
necessary to control their diabetes. It will require continued reinforcement, by providers with
insulin therapy expertise, to promote the need for insulin therapy education at the outset of a
patient’s journey with diabetes and that insulin is presented in a positive light.
At the patient level, the presence of psychological insulin resistance (PIR) has also been well
researched. The majority of participants in this study described some element of PIR during the
short interview component including such emotional elements as anxiety, depression, and fear of
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needles. Further research is necessary, however, to explore specific strategies and educational
modalities to decrease PIR concepts such as injection phobia, needle phobia, fear of weight gain,
hypoglycemia, and lifestyle accommodations (Larkin et al., 2008; Nam, et al., 2011).
Misconceptions and preconceptions regarding insulin therapy were clearly demonstrated in this
study. Many researchers have recommended introducing the concept of insulin therapy at the
outset or early into a patient’s journey with diabetes. Reluctance to the early introduction of the
concept of insulin therapy is found both in clinician and patient populations who would benefit
from further research to provide evidence of its benefit and promote adoption of early insulin
education as the norm in diabetes education and practice.
The ubiquitous nature of diabetes provides a strong case for increasing the awareness of diabetes
management including insulin therapy to a broader audience than just those living with diabetes.
As evidenced in this study, patients clearly listen to the narratives of their friends and family.
Indeed, research has shown that it is the information received from family and friends that is
often valued more highly than that received from healthcare professionals. Educating the general
public about the advances in diabetes management and insulin therapy at health fairs, in print
media such as popular magazines, electronic media, or social media may help to dispel some of
the misconceptions present today.
Future research to extend upon the findings of this study should be done in primary care settings
such as family health teams or Nurse-Practitioner Led clinics where the majority of diabetes
management actually occurs versus the specialized environment of the Diabetes Education
Centres. This would also allow for further exploration of the impact of the Best Practice
Guideline when utilized by providers not specialized in diabetes care. Further study needs to be
undertaken exploring coping processes in patients on insulin therapy, examining the relationship
between coping and glycemic control. Is there a difference in glycemic control between patients
who enact effective coping processes versus patients who do not? A qualitative study that
provides a more in-depth examination of the patient experience of the education process during
transition to insulin therapy would illuminate our understanding of the patient experience
identifying possible gaps education or clinical care. An intervention study that provided
alternative methods for decreasing stress when initiating insulin therapy such as guided
meditation, peer to peer support, or use of technology such as smartphone application may help
to identify which strategies are more effective in reducing diabetes-related stress.
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5.2.1 Implications for Nursing
Nurses are ideally positioned to advocate for, educate, and assist patients transitioning to insulin
therapy. With a presence in primary care, ambulatory care, acute care, and long term care nurses
have multiple contact points with patients and their families to dispel misconceptions of insulin
therapy. As direct care providers, nurses can advocate for the use of best practice guidelines and
the use of assessment tools to ensure patients receive patient-focused education. The use of a
brief stress screening tool or coping tool can help to tailor the diabetes education patients require
and ease the transition to insulin therapy. Nurse researchers should continue to explore
opportunities to improve the patient experience of transitioning to insulin therapy including the
influences of stress and coping as patients work to achieve insulin self-management.

5.3 Conclusions
Much has changed in the 94 years since the discovery of insulin. From purified beef and pork
insulin to human insulin analogs, from long, thick gauged needles to tiny, thin-walled pen tip
needles, the physical aspects of insulin therapy have advanced to the point where insulin pumps
can now deliver subcutaneous insulin in a pattern that mimics the normal human pancreas. It is
the psychological aspect of insulin therapy, however, that often prevent patients from achieving
optimal glycemic control. Stress and coping can be improved with structured Best Practice
Guideline education as evidenced by the findings of this study. For adults with Type 2 diabetes,
initiating insulin therapy can be a stressful experience but as Lazarus (2006) noted, from such an
experience can come reorganization of life in ways that leave a person more productive, engaged
and satisfied. Nurses and healthcare professionals have an important role in helping patients to
achieve such a result.
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Appendix B
RNAO Nursing Best Practice Guideline for the
Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes
Interview Evaluation Tool
Education Audit
Client Eligibility Criteria (all eligibility criteria must be met to proceed)
 Adults over 18 years of age
 Diagnosis of Type 2 diabetes
 Patient has received education by a diabetes educator at an organization that uses RNAO
BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes
Patient Identification: ____________________________________________________________
Date Data Collected: ____________________________________________________________
Organization / Site Data Collected from: ____________________________________________
Data Collector’s Initials: _________________________________________________________
Patient Age: __________
Patient highest level of education: _________
Gender: ______________
Duration of diabetes: ___________
Diabetes regimen: _________________

Please describe how you felt when you were asked to start using insulin.
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
What was the most challenging thing about starting insulin?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
What made it easier to start using insulin?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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1. Did your educator ask you about your beliefs about insulin therapy?
□ Yes
2. Did your educator ask you to set a goal for the education session?
□ Yes
3. Did your educator review:
a. the type(s) of insulin you are taking?
b. how the insulin works in your body?
c. how long the insulin can be kept at room temperature?
d. how to store your insulin?
e. if your insulin is compatible with other insulins?
f. how to inject your insulin?
g. how to safely dispose of your needles or syringes?

□ Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes

□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No
□ No

4. Did your educator review these topics related to Self Monitoring of Blood Glucose
(SMBG):
a. how often to test your blood sugar?
□ Yes
□ No
b. what the recommended blood sugar targets are?
□ Yes
□ No
c. how to ensure your meter is accurate?
□ Yes
□ No
d. how to apply blood to the test strip?
□ Yes
□ No
5. Did you receive basic nutrition information?

□Yes

□No

6. Did your educator review these topics related to hypoglycemia
(low blood sugar):
a. how to prevent low blood sugar?
b. the symptoms of low blood sugar?
c. how to treat low blood sugar ?
d. teach your family or support members how to help if
you have low blood sugar?

□ Yes
□ Yes
□ Yes

□ No
□ No
□ No

□ Yes

□ No

7. Did your educator review these items related to sick day management:
a. checking your blood sugar every 4 to 8 hours when ill?
□Yes
b. adjusting your insulin dose when you are ill?
□Yes
c. knowing when to be seen by a healthcare provider?
□Yes
d. using easily digested / liquid carbohydrates if can’t
tolerate solid food?
□Yes
e. how to prevent dehydration?
□Yes

□No
□No
□No
□ No
□ No
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Appendix C
Participant Letter of Information and Consent
Study Title: An Examination of Perceived Stress and Ways of Coping in Adult Patients
Who Initiate Insulin Therapy
Principal Investigator: Maureen Loft, NP, M.Sc.N., CDE (maloft@uwo.ca)
Faculty Supervisor: Dr. Cheryl Forchuk, RN, PhD, Associate Director Nursing Research
Western University, Arthur Labatt Family School of Nursing (cforchuk@uwo.ca)
Introduction:
In order to achieve the best blood sugar control, patients with type 2 diabetes may be started on
insulin. Research has previously shown that patients respond differently and have different
coping strategies when starting insulin therapy.
The purpose of this letter is to provide you with the information that you require to make an
informed decision about participating in this research. This letter contains important information
that you should understand about why the study is being conducted and what it will involve.
Please take the time to read this carefully and feel free to ask questions if anything is not clear or
there are words or phrases that you do not understand.
What is the purpose of the research?
The purpose of this research is to examine the relationships between perceived stress, ways of
coping, and education that is guided by a best practice guideline.
What does participation in the survey involve?
If you agree to participate in the study you will be asked to complete 3 questionnaires during
your two appointments with the education centre. One questionnaire will ask you questions
about your stress level. Another questionnaire will ask you about your ways of coping with
different situations. The third questionnaire will ask you about your confidence in giving
yourself an injection and managing your diet. The questionnaires will be completed during your
regularly scheduled visits to the Diabetes Education Center. The surveys will take
approximately 20 minutes to complete. All of your responses and health information will be
anonymous and kept confidential.
Who can be in the study?
Patients who are 18 years of age or older, speak and understand English, have type 2 diabetes
and are beginning or have recently begun insulin therapy may be asked to participate. Patients
cannot participate in the study if they have previous used insulin therapy or are unable to
complete the surveys.
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If you decide to participate, you will be asked to sign an informed consent form.
What are the possible risks?
There are no known risks involved in participating in this study. There is a small risk that some
questions may cause you to experience emotional discomfort or distress. Should you wish to end
your participation in the study you may do so without providing a reason and your care will not
be affected. Your primary care caregiver or Endocrinologist will continue to be available to
assist you.
What are the possible benefits?
Information provided by this study may be used by diabetes healthcare providers to improve
education that they provide to people with diabetes. It may assist healthcare providers to help
patients develop strategies for coping with their diabetes. You may not benefit directly although
completing the questionnaires may provide you with the opportunity to reflect on your personal
diabetes self-management and factors that influence it.
What is the cost of participating in the study?
There is no direct cost to you for participating in the study. You will be providing your time to
complete the questionnaires.
Will I be reimbursed for participating in the study?
You will not be paid to complete the surveys.
Your rights:
Participation in the study is voluntary. You can refuse to participate, refuse to answer any
questions or withdraw from the study at any time with no effect on your future care. You have
the right to be given all the important information about the study and what you will be asked to
do. You should only agree to participate in the study if you are satisfied and feel comfortable
that you know enough about the study. The study investigator may withdraw you from the study
if your continued participation could impair your health.
You do not waive any legal rights by signing the consent form.
How will confidentiality be maintained?
This study has been reviewed and approved by the Research Ethics Board for Health Sciences
Research involving Human Subjects at the University of Western Ontario. Your research
records will be kept confidential and stored in a locked cabinet in a secure office. If the study
results are published, your name will not be used and no information that identifies you will be
released or published without your explicit consent. Your confidentiality will be respected.
However, it is important to note that the original signed research consent form and the data
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which will follow will be included in your health record. Representatives of the research team,
ethics review board, or regulatory bodies, such as Health Canada, may require access to your
records for the purpose of monitoring the research.
All information collected during the study will be stored until the completion of the study and the
findings have been released. Your personal information will be destroyed within one year after
the study is complete. Electronic data and paper based data sheets and analysis will be kept
secured and destroyed through shredding or deletion and file removal ten years after publication
of the study results.
Who do I contact if I have a question about the study?
If you have any questions about this research study please feel free to contact:
Maureen Loft, NP, M.Sc.N., PhD student
If you have any questions regarding your rights as a study participant, or the conduct of the study
you may contact Dr. David Hill, Scientific Director, Lawson Health Research Institute.

Thank-you for your interest in this study.
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Consent form: Study Title: An Examination of Perceived Stress and Ways of Coping in
Adult Patients Who Initiate Insulin Therapy
I have read the Letter of Information, have had the nature of the study explained to me and I
agree to participate. All questions have been answered to my satisfaction. I have received a
copy of the patient information and consent form for this study.

Name of Participant ________________________________

Signature of Participant ________________________________

Name of person obtaining consent ________________________________

Signature of person obtaining consent ________________________________

Date ________________________________
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